Gastro-oesophageal reflux disease

K11_REFLUX

gastroesophageal reflux disease: A chronic disorder characterized by reflux of the gastric and/or duodenal contents into the distal esophagus. It is usually caused by incompetence of the lower esophageal sphincter. Symptoms include heartburn and acid indigestion. It may cause injury to the esophageal mucosa.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K21 Hospital discharge: ICD-9 — 5301A Cause of death: ICD-10 — K21 Cause of death: ICD-9 — 5301A 2 out of 7 registries used, show all original rules.	37318
4. Check minimum number of events None	37318
5. Include endpoints None	37318
6. Filter based on genotype QC (FinnGen only)	37318

Control definitions (FinnGen only)

Control exclude: K11_OESSTODUO

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: K20-K31
Name in latin: Morbus refluxualis gastro-oesophageus

NAME	K11_REFLUX
CONTROL_EXCLUDE	K11_OESSTODUO
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K21
HD_ICD_9	5301A
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K21
COD_ICD_9	5301A
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Gastro-oesophageal reflux disease based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	244622	129853	113501
Only index persons	222545	121042	101503
Unadjusted period prevalence (%)
Whole population	3.45	3.72	3.17
Only index persons	4.19	4.45	3.87
Median age at first event (years)
Whole population	54.59	56.28	52.67
Only index persons	54.66	56.25	52.76

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	37318	21875	15443
Unadjusted period prevalence (%)	7.19	7.46	6.81
Median age at first event (years)	56.33	55.36	57.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
33529: Matched controls
297833

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

UJF30

NOMESCO Finland

Ileoscopy through colon

3.4

323.0

3934

11147

N06AX21

ATC

duloxetine; oral

2.4

323.0

3684

14549

A02BX02

ATC

sucralfate; oral

3.8

323.0

1610

3939

J37.0

ICD-10 Finland

Chronic laryngitis

4.8

323.0

1468

2789

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

8.6

323.0

3610

4135

J01FA09

ATC

clarithromycin; systemic

1.7

323.0

9964

59944

J01DB01

ATC

cefalexin; oral

1.9

323.0

26702

200877

A02BC01

ATC

omeprazole; systemic

3.6

323.0

12872

43431

G44.2

ICD-10 Finland

Tension-type headache

2.4

323.0

4616

18537

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.3

323.0

3779

15868

M01AH01

ATC

celecoxib; oral (coxibs)

1.9

323.0

5803

29644

N05CF01

ATC

zopiclone; oral

1.7

323.0

10042

58631

K20

ICD-10 Finland

Oesophagitis

21.2

323.0

887

382

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

78.9

323.0

542

R42

ICD-10 Finland

Dizziness and giddiness

2.0

323.0

7011

34580

JBC00

NOMESCO Finland

Gastro-oesophageal antireflux operation

142.9

323.0

366

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.9

323.0

14424

60732

XF402

NOMESCO Finland

ECG with work load test

2.4

323.0

3867

15233

D02

ICPC

Abdominal pain epigastric

3.1

323.0

2015

5962

K22.4

ICD-10 Finland

Dyskinesia of oesophagus

182.5

323.0

386

R03BA05

ATC

fluticasone; inhalant

2.0

323.0

6046

29483

R07.3

ICD-10 Finland

Other chest pain

2.6

323.0

3246

11924

H02AB06

ATC

prednisolone; systemic

1.9

323.0

15648

94393

AA1AD

NOMESCO Finland

CT of head and brain

1.8

323.0

7209

39432

R07.4

ICD-10 Finland

Chest pain, unspecified

2.5

323.0

10214

44161

K29.7

ICD-10 Finland

Gastritis, unspecified

17.0

323.0

1305

707

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

39.1

323.0

1095

257

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

323.0

9354

38869

N06AA09

ATC

amitriptyline; systemic

2.4

323.0

3370

13513

A02BC04

ATC

rabeprazole; oral

5.6

323.0

5019

9146

J01MA02

ATC

ciprofloxacin; systemic

1.7

323.0

12231

74868

K29.3

ICD-10 Finland

Chronic superficial gastritis

69.5

323.0

1508

202

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

27.1

323.0

496

165

K22.7

ICD-10 Finland

Barrett oesophagus

79.6

323.0

915

105

N03AX16

ATC

pregabalin; oral

2.2

323.0

8391

39238

A02BC05

ATC

esomeprazole; systemic

5.9

323.0

21599

70279

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

323.0

15009

94258

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.5

323.0

7176

21300

J01MA12

ATC

levofloxacin; systemic

1.9

323.0

5815

29210

R06.0

ICD-10 Finland

Dyspnoea

2.3

323.0

8810

40101

6241

FHL

Fund application (Nissen)

191.6

323.0

405

N06AB04

ATC

citalopram; systemic

1.8

323.0

6791

35995

D03

ICPC

Heartburn

5.0

323.0

1452

2650

J01AA02

ATC

doxycycline; systemic

1.9

323.0

25547

188192

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.1

323.0

5188

24385

XJC02

NOMESCO Finland

Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter

53.5

323.0

434

K30

ICD-10 Finland

Functional dyspepsia

6.9

323.0

5006

7390

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

22.3

323.0

23277

27520

M54.5

ICD-10 Finland

Low back pain

1.9

323.0

10896

59870

XJC10

NOMESCO Finland

Oesophageal pH monitoring

82.2

323.0

573

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.8

323.0

6644

35296

UJD02

NOMESCO Finland

Gastroscopy

10.2

323.0

2968

2812

H02AB04

ATC

methylprednisolone; systemic

2.0

323.0

4746

22522

UDQ12

NOMESCO Finland

Flexible laryngoscopy

3.1

323.0

2127

6430

A03FA02

ATC

cisapride; oral, rectal

4.5

323.0

3843

8253

N02BE01

ATC

paracetamol; systemic, rectal

2.4

323.0

28779

214282

R01AD08

ATC

fluticasone; nasal

1.8

323.0

9260

52040

N05BA04

ATC

oxazepam; oral

1.8

323.0

7743

42433

N02AX02

ATC

tramadol; systemic, rectal

2.0

323.0

14413

82120

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

323.0

4441

18580

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.9

323.0

9512

51909

M03BX02

ATC

tizanidine; oral

1.7

323.0

20141

138450

R53

ICD-10 Finland

Malaise and fatigue

1.9

323.0

6313

32037

K92.0

ICD-10 Finland

Haematemesis

6.8

323.0

893

1186

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.9

323.0

6727

34961

G47.3

ICD-10 Finland

Sleep apnoea

1.9

323.0

6887

36174

J01CA04

ATC

amoxicillin; systemic

1.7

323.0

25729

196364

R01AD09

ATC

mometasone; nasal

1.7

323.0

14393

91228

P01AB01

ATC

metronidazole; oral, rectal

1.8

323.0

12844

76805

M01AH05

ATC

etoricoxib; oral

1.7

323.0

18952

130037

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.6

323.0

13080

83273

UJF32

NOMESCO Finland

Coloscopy

3.1

323.0

10742

39494

J01FA10

ATC

azithromycin; systemic

1.6

323.0

18086

126730

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.9

323.0

6825

35932

M79.6

ICD-10 Finland

Pain in limb

1.9

323.0

11796

66521

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

323.0

11589

72278

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

4.5

323.0

1439

2941

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

213.1

323.0

19694

1977

K22.2

ICD-10 Finland

Oesophageal obstruction

136.5

323.0

455

R13

ICD-10 Finland

Dysphagia

5.0

323.0

3140

6034

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

2.3

323.0

4232

17885

L03

ICPC

Low back symptom/complaint

1.9

323.0

7706

40618

Z01.8

ICD-10 Finland

Other specified special examinations

2.3

323.0

7926

34795

5301A

ICD-9 Finland

Diseases of oesophagus, Oesophagitis[OESOPHAGITIS REFLUENS]

+∞

323.0

813

R12

ICD-10 Finland

Heartburn

4.7

323.0

3590

7348

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.8

323.0

7517

40991

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.7

323.0

12726

80239

R05

ICD-10 Finland

Cough

2.2

323.0

6789

30831

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.1

323.0

14987

83188

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.6

323.0

2250

5805

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

7.0

323.0

1014

1315

M01AE02

ATC

naproxen; oral, rectal

1.6

323.0

17880

123643

WX002

NOMESCO Finland

Sedation and analgesia

1.9

323.0

6257

32197

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.7

323.0

9920

58348

M25.5

ICD-10 Finland

Pain in joint

1.8

323.0

9224

51070

R03AC02

ATC

salbutamol; inhalant

2.1

323.0

18233

109091

N06AX11

ATC

mirtazapine; oral

1.9

323.0

10451

57510

A02BA04

ATC

nizatidine; systemic

3.1

323.0

2998

9075

A03FA01

ATC

metoclopramide; systemic, rectal

1.9

323.0

6784

34511

K22.1

ICD-10 Finland

Ulcer of oesophagus

249.1

323.0

1239

A02BA02

ATC

ranitidine; systemic

3.9

323.0

9603

27829

R11

ICD-10 Finland

Nausea and vomiting

2.8

323.0

2707

9006

J02AC01

ATC

fluconazole; systemic

1.7

323.0

12734

77596

N03AX12

ATC

gabapentin; oral

2.2

323.0

5330

23302

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.7

323.0

12670

78883

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

323.0

6201

27292

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

227.1

323.0

2855

122

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.6

323.0

15948

107746

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

15.2

323.0

6800

4902

SPAT1263

SPAT

Sampling

1.8

323.0

13807

84939

R03DC03

ATC

montelukast; oral

2.1

323.0

5342

25143

R51.80

ICD-10 Finland

Headache

2.4

323.0

5068

20716

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.7

323.0

6449

24377

A02BC02

ATC

pantoprazole; systemic

4.8

323.0

26862

135758

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

118.5

323.0

17709

2794

M79.1

ICD-10 Finland

Myalgia

2.1

323.0

4152

18440

A02BC03

ATC

lansoprazole; oral

4.1

323.0

14459

46799

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

2.2

323.0

7297

33378

C07AB07

ATC

bisoprolol; oral

1.7

323.0

14492

91950

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

321.9

5549

28011

M70.6

ICD-10 Finland

Trochanteric bursitis

2.2

319.9

3849

16805

WX408

NOMESCO Finland

General anesthesy, balanced

1.7

319.7

8450

49045

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.8

314.7

6023

31522

R06AE07

ATC

cetirizine; oral

1.6

314.0

13347

87923

M01AB05

ATC

diclofenac; systemic, rectal

1.6

312.2

20979

154120

SAA01

NOMESCO Finland

Simple examination of mouth

1.6

311.5

21844

162085

K29.1

ICD-10 Finland

Other acute gastritis

22.3

311.0

476

192

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.4

309.3

2887

11142

Z01.2

ICD-10 Finland

Dental examination

1.6

305.1

12549

81805

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

304.2

17026

119451

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

298.9

8763

52199

D01

ICPC

Abdominal pain/cramps general

2.2

298.3

3295

13806

J01FA06

ATC

roxithromycin; oral

1.6

298.1

12451

81333

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

297.7

5092

25552

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

297.5

5426

27861

M02AA07

ATC

piroxicam; topical

1.6

296.6

11173

71102

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

296.0

4381

20808

L01

ICPC

Neck symptom/complaint

2.0

295.9

4261

20023

M01AC06

ATC

meloxicam; systemic, rectal

1.6

295.7

11331

72407

A03CA02

ATC

clidinium and psycholeptics; oral

2.8

295.5

2065

6744

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

294.9

3414

14613

S18

ICPC

Laceration/cut

1.6

293.3

12669

83337

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

2.1

291.6

3624

16004

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

2.5

290.8

2629

9963

SPAT1153

SPAT

Removal of sutures

1.6

290.1

9838

60850

XJC00

NOMESCO Finland

Oesophageal manometry

64.6

289.7

352

UKC02

NOMESCO Finland

Cystoscopy

1.9

289.2

4860

24206

A02BA03

ATC

famotidine; systemic

3.6

287.5

1419

3607

M01AX17

ATC

nimesulide; oral

1.7

286.8

7560

43591

A02BD03

ATC

lansoprazole, amoxicillin and metronidazole; systemic

2.6

286.6

2252

7892

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

286.5

14737

100826

K29.8

ICD-10 Finland

Duodenitis

101.4

285.7

328

R01AD12

ATC

fluticasone furoate; nasal

1.6

284.0

8993

54555

I10

ICD-10 Finland

Essential (primary) hypertension

1.5

283.4

17040

120660

K31.8

ICD-10 Finland

Other specified diseases of stomach and duodenum

377.0

281.6

296

WX110

NOMESCO Finland

Local anesthesy

1.5

280.6

21255

158343

K29.6

ICD-10 Finland

Other gastritis

26.8

279.0

405

136

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

276.1

11511

74753

J01DA01

ATC

[U] cefalexin; systemic

1.5

275.7

19389

141757

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.5

275.6

12360

81659

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.1

274.1

3700

16894

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

37.2

272.4

365

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

110.8

271.6

309

M03BC01

ATC

orphenadrine (citrate); systemic

1.7

271.2

7172

41284

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

268.7

2121

7443

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.5

266.1

12633

84362

R03BA02

ATC

budesonide; inhalant

1.8

265.6

5381

28508

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.2

263.8

3105

13353

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.7

262.5

6974

40135

N06AX16

ATC

venlafaxine; oral

1.9

260.7

4227

20706

D64.9

ICD-10 Finland

Anaemia, unspecified

2.3

260.5

2799

11539

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.8

260.2

5339

28381

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

2.1

258.6

3522

16114

R03AK07

ATC

formoterol and budesonide; inhalant

1.8

258.6

5854

32101

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

255.6

16003

113230

A06AD11

ATC

lactulose; oral

1.9

255.4

4038

19581

L08

ICPC

Shoulder symptom/complaint

1.8

255.2

5720

31254

A02BDXX

ATC

3.6

252.2

1241

3142

M01AH02

ATC

rofecoxib; oral

1.9

251.3

4049

19765

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.3

250.5

2596

10509

K92.1

ICD-10 Finland

Melaena

3.2

248.7

1455

4205

C07AA05

ATC

propranolol; systemic

1.7

248.2

5766

31822

R02

ICPC

Shortness of breath/dyspnoea

2.0

247.9

3581

16755

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.6

247.6

1961

6884

C05AA08

ATC

fluocortolone; rectal, topical

1.9

246.9

4464

22699

R03BA08

ATC

ciclesonide; inhalant

2.2

245.7

2672

11064

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.7

244.3

6227

35304

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

243.2

8451

52091

R07.0

ICD-10 Finland

Pain in throat

2.6

242.0

1953

6927

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

241.3

6067

34242

H02AB07

ATC

prednisone; oral

1.9

240.0

4297

21756

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

2.0

238.2

3370

15624

A06AC51

ATC

ispaghula, combinations; systemic

2.8

237.0

1673

5477

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.1

235.9

3135

14165

R05

ICPC

Cough

1.7

235.5

6539

37933

K29.4

ICD-10 Finland

Chronic atrophic gastritis

14.7

231.2

410

251

L17

ICPC

Foot/toe symptom/complaint

1.6

230.8

7313

43913

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.0

227.9

3527

16914

M01AB55

ATC

diclofenac, combinations; oral

2.4

227.6

2167

8396

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

2.1

227.2

2868

12671

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

226.8

19271

143553

J45.0

ICD-10 Finland

Predominantly allergic asthma

2.2

225.3

2639

11282

JN3AD

NOMESCO Finland

Abdominal CT examination

2.3

223.9

2327

9411

R03BB04

ATC

tiotropium bromide; inhalant

2.1

223.8

2893

12906

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.8

223.8

4290

22188

A07AA02

ATC

nystatin; oral

2.5

223.2

1954

7240

M79.0

ICD-10 Finland

Rheumatism, unspecified

3.3

222.0

1244

3480

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

2.2

221.4

2392

9853

R01BA52

ATC

pseudoephedrine, combinations; oral

1.5

220.8

9271

59516

JC2AB

NOMESCO Finland

Oesophagus X-ray examination with contrast

10.3

219.8

458

398

R52.9

ICD-10 Finland

Pain, unspecified

2.2

218.7

2566

10974

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.0

216.4

3250

15390

UDH02

NOMESCO Finland

Rhinopharyngoscopy

2.4

216.2

2090

8153

R00.2

ICD-10 Finland

Palpitations

2.3

215.8

2180

8691

J01FF01

ATC

clindamycin; systemic

1.6

215.8

7989

49735

A01AB09

ATC

miconazole; local oral

2.1

215.5

2672

11702

J31.0

ICD-10 Finland

Chronic rhinitis

2.2

213.5

2402

10074

SPAT1312

SPAT

General health counselling

1.5

213.5

9391

60824

XG410

NOMESCO Finland

Flow-volume spirometry

2.9

213.5

1416

4450

SPAT1310

SPAT

Counselling related to known health issue

1.5

212.9

9414

61037

C03CA01

ATC

furosemide; systemic

1.6

212.0

7441

45688

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.7

211.0

4855

26565

J45.1

ICD-10 Finland

Nonallergic asthma

2.3

210.3

2175

8764

H04.10

ICD-10 Finland

Dry eye syndrome

2.0

210.0

2947

13580

K59.0

ICD-10 Finland

Constipation

2.6

209.3

1674

5895

SPAT1301

SPAT

No procedures

1.5

208.8

9207

59595

L13

ICPC

Hip symptom/complaint

1.8

208.5

4492

24079

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.6

208.1

6808

41044

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.7

207.0

1540

5196

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.5

206.0

8318

52742

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

2.3

205.9

2099

8397

K59.09

ICD-10 Finland

Constipation, unspecified

2.5

205.7

1803

6679

K02.1

ICD-10 Finland

Caries of dentine

1.4

205.7

16749

122627

N06AB10

ATC

escitalopram; oral

1.6

204.9

5700

32909

N05AH04

ATC

quetiapine; oral

1.7

204.0

4612

25076

K59.1

ICD-10 Finland

Functional diarrhoea

2.7

203.9

1576

5440

C01DA14

ATC

isosorbide mononitrate; oral

1.8

203.4

3919

20249

R05FB02

ATC

cough suppressants and expectorants

1.5

202.2

11073

74947

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

202.1

5971

35022

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

2.4

201.8

1846

6991

C10AA01

ATC

simvastatin; oral

1.5

201.5

12109

83492

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

2.8

199.4

1430

4717

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.5

198.7

9619

63389

R96

ICPC

Asthma

2.1

198.5

2585

11540

M01AX05

ATC

glucosamine; oral

1.6

198.1

5682

33042

J45

ICD-10 Finland

Asthma

2.0

198.1

2886

13480

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.5

197.3

8877

57560

K25.3

ICD-10 Finland

Gastric ulcer, Acute without haemorrhage or perforation

85.3

195.8

229

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

195.3

16992

125410

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

2.6

193.3

1525

5322

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

193.1

11825

81627

C08CA01

ATC

amlodipine; oral

1.5

192.2

9861

65668

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.8

191.4

4067

21655

SPAT1097

SPAT

Recording of ECG

1.7

191.4

4290

23224

XQ800

NOMESCO Finland

Prick test

2.1

191.0

2266

9712

C10AA05

ATC

atorvastatin; oral

1.5

190.1

10699

72570

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.6

189.7

5829

34464

L15

ICPC

Knee symptom/complaint

1.6

189.6

5934

35251

E0000UV

ATC

1.4

188.8

11328

77785

D06

ICPC

Abdominal pain localized other

2.1

187.5

2320

10126

K22.0

ICD-10 Finland

Achalasia of cardia

576.4

187.2

194

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

3.0

187.2

1176

3560

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.5

186.6

7499

47298

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.8

186.0

3369

17014

M48.0

ICD-10 Finland

Spinal stenosis

1.8

185.9

3339

16815

N05BA12

ATC

alprazolam; oral

1.9

185.8

3039

14805

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.9

185.7

1245

3934

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.5

185.0

7606

48206

M53.0

ICD-10 Finland

Cervicocranial syndrome

2.0

184.3

2462

11091

K25.0

ICD-10 Finland

Gastric ulcer, Acute with haemorrhage

131.5

184.1

206

N05CF02

ATC

zolpidem; oral

1.6

183.8

5102

29333

K44

ICD-10 Finland

Diaphragmatic hernia

8.6

183.7

425

446

J01EA01

ATC

trimethoprim; systemic

1.5

183.1

7025

43804

N05BA01

ATC

diazepam; systemic, rectal

1.8

182.8

3807

20121

SPAT1058

SPAT

PEF monitoring instruction

2.0

181.9

2465

11169

K26.9

ICD-10 Finland

Duodenal ulcer, unspecified as acute or chronic, without haemorrhage or perforation

98.3

181.7

209

N06AB03

ATC

fluoxetine; oral

1.8

181.5

3652

19086

K29.0

ICD-10 Finland

Acute haemorrhagic gastritis

101.8

178.8

205

J20

ICD-10 Finland

Acute bronchitis

1.9

177.9

2753

13128

Z09.0

ICD-10 Finland

Follow-up examination after surgery for other conditions

2.1

177.8

2333

10429

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.1

177.4

2298

10216

UGC12

NOMESCO Finland

Flexible bronchoscopy

2.1

177.4

2206

9639

R06AX27

ATC

desloratadine; oral

1.5

176.5

7662

49057

M79.7

ICD-10 Finland

Fibromyalgia

3.1

176.3

1075

3186

R03BA01

ATC

beclometasone; inhalant

1.7

174.9

4037

21997

A02BD07

ATC

lansoprazole, amoxicillin and clarithromycin; systemic

2.6

174.6

1384

4840

UJF92

NOMESCO Finland

Capsular endoscopy

4.3

174.3

693

1448

N05CD07

ATC

temazepam; oral

1.8

173.5

3395

17568

C07AB02

ATC

metoprolol; systemic

1.6

173.3

5578

33274

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

173.3

4490

25288

A01

ICPC

Pain general/multiple sites

2.1

172.9

2167

9499

M54.2

ICD-10 Finland

Cervicalgia

2.1

172.5

2089

9022

R21

ICPC

Throat symptom/complaint

1.6

171.9

5284

31149

A11

ICPC

Chest pain NOS

2.1

171.4

2140

9363

SPAT1249

SPAT

Treatment-related counselling outside office

1.4

171.0

11430

79687

K22.9

ICD-10 Finland

Disease of oesophagus, unspecified

34.2

170.9

233

R74

ICPC

Upper respiratory infection acute

1.5

169.9

7693

49632

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.1

169.2

2098

9150

J01CA08

ATC

pivmecillinam; oral

1.4

169.0

10867

75171

R03AC03

ATC

terbutaline; inhalant

1.7

168.3

4006

22007

R35

ICD-10 Finland

Polyuria

2.2

168.3

1833

7547

WX320

NOMESCO Finland

Spinalanesthesy

1.5

167.7

6405

39771

R49.01

ICD-10 Finland

Functional dysphonia

3.1

167.3

1013

2989

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

167.1

3086

15650

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.9

167.1

2745

13367

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

166.7

5164

30477

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

166.6

10960

76079

M54.6

ICD-10 Finland

Pain in thoracic spine

2.1

165.7

1959

8366

5308A

ICD-9 Finland

Diseases of oesophagus, Other specified disorders of oesophagus[HERNIA HIATUS OESOPHAGI (""""SLIDING HERNIA"""")]

+∞

165.3

166

SPAT1260

SPAT

Consultation of another employee

1.6

164.7

5049

29703

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

2.4

164.4

1485

5574

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.8

163.2

1131

3647

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.7

162.9

3824

20906

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

162.8

3799

20731

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

159.8

162.6

179

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

6.5

162.5

450

620

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

162.5

3696

20015

SPAT1254

SPAT

Administration of medicine

1.7

160.7

3973

22041

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.3

160.7

1575

6161

R03AK08

ATC

formoterol and beclometasone; inhalant

2.7

160.4

1204

4074

C10AC01

ATC

colestyramine; oral

3.4

159.7

852

2293

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

159.4

12667

90734

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

2.1

159.3

2095

9358

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.9

159.3

2677

13130

D07AC01

ATC

betamethasone; topical

1.4

157.9

9652

65923

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

157.8

6118

38044

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

157.2

1902

8200

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

156.2

6883

44012

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.8

155.8

3075

15917

N30.0

ICD-10 Finland

Acute cystitis

1.7

155.8

3670

20064

C09CA06

ATC

candesartan; oral

1.5

154.1

6005

37354

A04

ICPC

Weakness/tiredness general

1.7

154.0

3422

18381

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

153.8

2958

15181

M54

ICD-10 Finland

Dorsalgia

1.8

153.7

3111

16232

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

153.4

5838

36118

N04BC05

ATC

pramipexole; oral

2.0

153.3

2074

9365

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

152.8

11622

82429

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.5

152.2

7509

49115

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.7

152.2

4017

22669

K22.6

ICD-10 Finland

Gastro-oesophageal laceration-haemorrhage syndrome

355.0

152.0

160

G04BD12

ATC

mirabegron; oral

1.8

150.8

2775

14029

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

2.3

150.8

1530

6084

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.9

150.5

2624

13024

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

150.5

4804

28485

M02AA10

ATC

ketoprofen; topical

1.6

149.7

4489

26198

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

2.0

149.4

2074

9462

R06.5

ICD-10 Finland

Mouth breathing

1.9

148.7

2513

12336

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

148.6

2316

11040

N01

ICPC

Headache

1.8

148.5

2649

13250

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.1

147.9

1735

7377

D82

ICPC

Teeth/gum disease

1.4

147.6

9636

66418

N17

ICPC

Vertigo/dizziness

1.8

147.2

2941

15270

XG474

NOMESCO Finland

Exhalation nntrogen oxide

3.0

147.1

928

2814

R52.2

ICD-10 Finland

Other chronic pain

2.8

146.8

1015

3266

G04CA02

ATC

tamsulosin; oral

1.5

146.5

5698

35381

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.9

146.2

2312

11080

L02

ICPC

Back symptom/complaint

1.9

145.9

2458

12049

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.7

145.6

3469

19002

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.9

145.5

2355

11381

WZA90

NOMESCO Finland

Other doctors statement

1.5

145.1

6343

40392

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.1

145.0

1821

7970

K44.0

ICD-10 Finland

Diaphragmatic hernia with obstruction, without gangrene

14.5

144.9

257

158

K25.4

ICD-10 Finland

Gastric ulcer, Chronic or unspecified with haemorrhage

93.2

144.4

167

SPAT1325

SPAT

Vaccination

1.4

144.3

9511

65603

G04BD08

ATC

solifenacin; oral

2.1

142.6

1870

8329

J01MA01

ATC

ofloxacin; systemic

1.9

141.3

2415

11893

H03AA01

ATC

levothyroxine sodium; systemic

1.5

141.2

6409

41104

SPAT1104

SPAT

Monitoring of emergency patient

2.0

140.3

1891

8518

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

140.0

2206

10554

UJC12

NOMESCO Finland

Flexible oesophagoscopy

9.0

139.8

314

F45.8

ICD-10 Finland

Other somatoform disorders

2.0

138.6

1859

8355

C10AA07

ATC

rosuvastatin; oral

1.5

138.2

6567

42489

R03AC12

ATC

salmeterol; inhalant

2.4

138.1

1288

4908

A07EA06

ATC

budesonide; oral, local oral

2.7

138.1

992

3268

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

5.2

137.9

459

796

H25.8

ICD-10 Finland

Other senile cataract

1.8

137.5

2678

13773

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.4

137.5

7278

48103

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.8

137.3

2814

14713

N03AE01

ATC

clonazepam; systemic

2.1

136.0

1646

7086

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

135.0

7739

51899

D11

ICPC

Diarrhoea

1.7

134.3

2900

15403

NF1AA

NOMESCO Finland

Hip X-ray examination

1.9

134.3

2297

11306

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.8

134.3

2426

12170

K31.7

ICD-10 Finland

Polyp of stomach and duodenum

63.3

134.2

163

N06AB06

ATC

sertraline; oral

1.7

133.9

2926

15598

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

132.8

1840

8374

B01AB05

ATC

enoxaparin; parenteral

1.4

132.6

8283

56396

WX290

NOMESCO Finland

Other blockade of nerve

1.3

132.6

12223

88859

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.8

132.2

927

3007

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.3

132.1

1274

4936

SPAT1211

SPAT

Application of soft bandage

1.8

131.6

2506

12790

R06AX22

ATC

ebastine; oral

1.5

130.7

4720

28727

F51.0

ICD-10 Finland

Nonorganic insomnia

1.6

130.5

3405

19094

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.5

129.7

5327

33367

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.7

129.3

3165

17430

R60.0

ICD-10 Finland

Localized oedema

1.7

129.2

2879

15425

G04CA01

ATC

alfuzosin; oral

1.7

128.7

2999

16285

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.3

128.5

1240

4804

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.9

128.3

2074

10001

G43.9

ICD-10 Finland

Migraine, unspecified

2.2

127.9

1479

6236

H53.1

ICD-10 Finland

Subjective visual disturbances

2.0

127.9

1714

7697

S06.0

ICD-10 Finland

Concussion

1.7

127.4

2732

14468

SPAT1240

SPAT

Therapeutic discussion

1.7

127.4

2757

14641

N02AA05

ATC

oxycodone; systemic

1.6

127.4

3662

21064

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.4

127.3

7304

48896

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.4

126.9

7558

50940

M01AE01

ATC

ibuprofen; systemic, rectal

1.4

126.9

28037

232551

N39.3

ICD-10 Finland

Stress incontinence

1.9

126.8

1964

9323

L16

ICPC

Ankle symptom/complaint

1.7

126.7

2683

14155

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.4

126.3

1118

4143

R51

ICD-10 Finland

Headache

2.2

126.3

1415

5884

E66.01

ICD-10 Finland

Obesity due to excess calories

1.9

126.0

2116

10341

XKD00

NOMESCO Finland

Uroflowmetry

1.6

125.9

4091

24260

J01MA06

ATC

norfloxacin; oral

1.6

125.7

3655

21081

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.8

125.5

2292

11526

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.4

124.8

9164

64032

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.8

124.7

2276

11442

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.7

124.7

2876

15561

A04.8

ICD-10 Finland

Other specified bacterial intestinal infections

4.9

124.5

437

804

A01AB04

ATC

amphotericin B; local oral

2.2

122.6

1343

5528

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.7

122.5

2553

13395

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.9

122.3

2097

10319

L28

ICPC

Limited function/disability (L)

1.6

122.0

3947

23366

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

121.9

5283

33416

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.5

121.8

5205

32825

R06.2

ICD-10 Finland

Wheezing

2.3

121.2

1230

4883

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.5

121.1

4225

25467

R06AE09

ATC

levocetirizine; oral

1.6

121.0

3921

23222

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

120.0

2107

10452

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.9

119.4

1849

8770

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.6

119.2

3508

20272

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.0

119.0

1584

7087

K07.60

ICD-10 Finland

Snapping jaw

2.2

118.8

1338

5575

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.6

118.3

3204

18118

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

2.1

116.9

1508

6661

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

2.3

116.7

1154

4524

N81.6

ICD-10 Finland

Rectocele

2.0

116.7

1724

8034

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.5

116.6

4027

24193

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

116.6

1732

8088

K26.3

ICD-10 Finland

Duodenal ulcer, acute without haemorrhage or perforation

163.0

116.6

128

R50.9

ICD-10 Finland

Fever, unspecified

1.6

116.6

3627

21249

K08.80

ICD-10 Finland

Toothache NOS

1.8

116.5

2111

10580

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

115.6

1992

9815

R55

ICD-10 Finland

Syncope and collapse

1.7

114.9

2719

14803

N41.1

ICD-10 Finland

Chronic prostatitis

3.0

114.8

698

2064

X58

ICD-10 Finland

Exposure to other specified factors

1.6

114.7

3630

21349

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.2

114.4

1244

5101

A07EC02

ATC

mesalazine; oral, rectal

2.1

114.0

1479

6547

R49.08

ICD-10 Finland

Other specified dysphonia

3.1

113.7

678

1977

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.5

113.6

992

3649

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.0

113.4

1637

7557

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.7

112.9

2540

13622

M01AG02

ATC

tolfenamic acid; oral, rectal

1.5

112.7

4113

25012

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

112.7

3475

20303

K26.0

ICD-10 Finland

Duodenal ulcer, acute with haemorrhage

1024.0

112.5

115

XF404

NOMESCO Finland

Ambulatory ECG

1.7

112.5

2449

13007

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

2.1

112.0

1429

6279

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.7

111.7

2860

15913

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

111.5

795

2605

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.5

111.3

4322

26641

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.3

111.0

1118

4420

I20.99

ICD-10 Finland

Angina pectoris, unspecified

2.0

111.0

1628

7560

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

2.1

111.0

1350

5816

SPAT1216

SPAT

Assessment of functional ability

1.5

110.8

3901

23518

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.6

110.3

3562

21041

L12

ICPC

Hand/finger symptom/complaint

1.6

110.1

3684

21945

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

109.6

3352

19534

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

4.3

109.4

436

914

K22.8

ICD-10 Finland

Other specified diseases of oesophagus

43.3

109.1

141

ZXA10

NOMESCO Finland

Bilateral

1.5

108.6

4915

31280

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

108.6

2274

11930

A02BD02

ATC

lansoprazole, tetracycline and metronidazole; systemic

3.0

108.5

670

1999

J01CE02

ATC

phenoxymethylpenicillin; oral

1.3

108.1

20240

160896

R5140

NOMESCO Finland

Monitoring the use of the aid

1.6

107.5

2805

15680

DFF00

NOMESCO Finland

Pure tone audiometry

1.7

107.3

2368

12619

U02

ICPC

Urinary frequency/urgency

1.6

106.7

3291

19210

WX722

NOMESCO Finland

PEEP

2.1

105.7

1302

5637

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

2.5

104.9

896

3257

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

104.7

3777

22876

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.5

104.5

3947

24153

N06AA12

ATC

doxepin; systemic

2.0

104.4

1414

6364

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.6

104.1

3101

17938

R03AC13

ATC

formoterol; inhalant

2.1

103.8

1337

5896

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

6.2

103.8

296

426

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

2.4

103.7

938

3511

Z00.0

ICD-10 Finland

General medical examination

1.5

103.5

4838

30960

J34.2

ICD-10 Finland

Deviated nasal septum

2.0

103.4

1453

6636

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

2.0

103.3

1440

6552

AN1

Coronary angiography

1.6

103.3

2890

16449

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.8

103.0

2044

10536

M54.3

ICD-10 Finland

Sciatica

1.9

103.0

1576

7432

C08CA05

ATC

nifedipine; systemic

1.9

102.9

1654

7943

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.8

102.7

1785

8807

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.7

102.6

2437

13264

R01AD11

ATC

triamcinolone; nasal

1.7

102.5

2396

12978

CK2S4

NOMESCO Finland

Plain photography of ocular fundus

1.9

102.4

1630

7798

C09CA01

ATC

losartan; oral

1.4

102.3

6284

42316

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.4

102.3

5768

38249

H92.0

ICD-10 Finland

Otalgia

2.0

102.2

1334

5915

R32

ICD-10 Finland

Unspecified urinary incontinence

2.7

101.6

767

2601

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.1

101.5

1286

5633

K58

ICD-10 Finland

Irritable bowel syndrome

2.9

101.4

668

2084

J02AC02

ATC

itraconazole; systemic

1.4

101.1

4878

31401

N07CA01

ATC

betahistine; oral

1.8

101.0

1968

10083

B01AC04

ATC

clopidogrel; oral

1.5

100.8

3768

22990

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4010399)

3868

17913

2.02

320.99

1.5

1.4

—

(3005719) IgG [Mass/volume] in Serum or Plasma

3910

18236

2.00

317.95

2.7

10.4

10.6

g/l

1.90

3554

16700

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

31981

254818

1.78

314.49

16.4

12.3

80.1

81.6

ml/min/173m2

31.82

27262

209453

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

7079

39929

1.70

311.33

2.0

1.8

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

23435

152516

1.97

307.65

5.3

4.4

6.6

6.7

mmol/l

5.94

22138

142299

(3019550) Sodium [Moles/volume] in Serum or Plasma

34927

278005

2.76

307.65

21.1

14.8

139.6

139.7

mmol/l

9.71

34224

270933

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

13612

84597

1.67

307.65

3.5

3.1

33.9

33.6

u/l

0.11

12833

80189

(3004789) Transferrin [Mass/volume] in Serum or Plasma

6846

35351

1.88

307.65

2.7

2.4

2.3

g/l

17.81

6263

32687

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

17258

106410

1.81

307.65

2.6

2.2

77.9

930.8

nmol/l

0.50

15261

96077

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

6954

30726

2.23

307.65

4.8

4.4

32.4

32.1

1.48

4850

21052

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

10598

61171

1.75

307.65

2.5

2.2

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

9984

55878

1.79

307.65

1.9

1.7

1.0

1.2

mg/l

6.97

7400

42890

(3032080) INR in Blood by Coagulation assay

17012

103277

1.84

307.65

8.6

1.2

1.3

inr

6.32

4676

30348

(3001604) Monocytes [#/volume] in Blood

20588

129579

1.91

307.65

6.4

5.7

0.6

e9/l

0.53

18244

111592

(3021960) Folate [Moles/volume] in Serum or Plasma

10356

56594

1.86

307.65

1.6

1.5

21.0

20.3

nmol/l

3.04

8639

48587

(3013139) Helicobacter pylori Ag [Presence] in Stool

4221

14596

2.76

307.65

1.2

—

(3019225) pH of Specimen

5937

23820

2.44

307.65

4.3

4.1

—

(3031040) Bacteria [#/volume] in Urine by Automated count

25379

171427

1.97

307.65

5.6

4.1

967.4

1410.0

e6/l

0.93

247

2561

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

2496

9472

2.43

307.65

4.3

3.9

24.8

mmol/l

0.57

2328

8749

(36660697) Celiac disease serology panel - Serum

4102

19176

2.00

307.65

1.2

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

22808

151149

1.86

307.65

9.0

4.1

e9/l

0.79

20352

131506

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

17756

102767

2.01

307.65

2.2

1.9

99.0

96.1

pmol/l

10.89

9260

53251

(3044640) Blood type and Crossmatch panel - Blood

13395

80897

1.73

307.65

2.6

2.3

—

(3009343) pH of Capillary blood

3543

15208

2.17

307.65

4.0

3.6

7.4

0.59

369

2065

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

3754

17047

2.06

307.65

1.7

1.6

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

2798

7705

3.40

307.65

1.6

—

(3048689) Calprotectin [Mass/mass] in Stool

7086

28793

2.46

307.65

2.5

2.3

131.4

133.1

ug/g

0.15

5508

22512

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

32915

261313

1.98

307.65

5.5

4.4

6.0

5.9

mmol/l

11.83

29785

239521

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

25325

177173

1.83

307.65

4.0

2.9

51.8

47.4

u/l

9.44

23513

165555

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

10811

53716

2.10

307.65

1.4

1.3

1.7

u/ml

0.04

2605

14895

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

35235

289594

2.39

307.65

13.4

9.7

26.6

26.5

u/l

0.43

34105

279445

(3006504) Eosinophils/100 leukocytes in Blood

19760

121533

1.93

307.65

6.6

5.9

2.9

1.73

18324

113436

(3024561) Albumin [Mass/volume] in Serum or Plasma

18134

110284

1.89

307.65

5.2

4.6

35.8

35.6

g/l

5.08

16764

102176

(3023103) Potassium [Moles/volume] in Serum or Plasma

34960

278876

2.74

307.65

21.2

14.9

4.0

mmol/l

0.94

34193

271323

(3036481) Cortisol [Moles/volume] in Serum or Plasma

4595

22174

1.95

307.65

2.2

2.3

362.1

375.7

nmol/l

3.72

4175

20484

(3022096) Basophils/100 leukocytes in Blood

19152

117954

1.90

307.65

6.7

6.0

0.7

1.83

17749

110145

(40768797) Stomach Pathology biopsy report

13901

24348

7.46

307.65

1.3

1.1

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

5478

27761

1.88

307.65

2.7

2.6

7.3

8.6

umol/l

5.18

4734

24045

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

9107

53546

1.67

307.65

1.7

72387892.1

29808862.8

pmol/l

4.87

7464

44266

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

12609

70329

1.89

307.65

3.1

2.9

1272.7

1351.8

ng/l

0.97

10373

60135

(3018010) Neutrophils/100 leukocytes in Blood

19962

123828

1.92

307.65

6.5

5.8

56.9

57.2

2.74

18472

116127

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

7588

42035

1.75

307.65

1.3

9.7

12.2

u/ml

2.09

2595

16780

(3001122) Ferritin [Mass/volume] in Serum or Plasma

17921

109386

1.87

307.65

3.4

2.7

121.6

132.2

ug/l

4.09

16434

101489

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

19143

115696

1.96

307.65

6.5

5.8

1.2

mmol/l

7.18

17008

104915

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

28550

204725

2.00

307.65

4.7

3.9

14.8

14.7

pmol/l

5.41

25863

186765

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

18226

122513

1.62

307.65

4.4

3.8

—

(3019198) Lymphocytes [#/volume] in Blood

21042

133617

1.90

307.65

6.4

5.8

1.9

e9/l

0.20

18880

117263

(3005322) IgE [Units/volume] in Serum or Plasma

3504

15533

2.10

307.65

1.4

1.3

175.7

254.3

u/ml

4.59

3266

14392

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2056

6270

3.01

307.65

1.5

1.4

284.6

271.0

ug/g

1.99

1156

3635

(3006315) Basophils [#/volume] in Blood

20732

130155

1.92

307.65

6.4

5.7

0.0

e9/l

1.83

18351

112082

(3022948) Iron [Moles/volume] in Serum or Plasma

7365

38375

1.87

307.65

2.7

2.4

13.1

13.9

umol/l

0.88

6759

35574

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

16342

76952

2.57

307.65

3.0

2.4

57.7

58.5

u/l

0.60

15029

70856

(3022313) Gas panel - Capillary blood

2735

10922

2.31

307.65

4.1

3.8

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

13485

77225

1.86

307.65

2.3

2.1

176.0

212.2

u/l

3.44

12669

72317

(3015377) Calcium [Moles/volume] in Serum or Plasma

13680

86980

1.62

307.65

3.0

3.4

2.3

2.4

mmol/l

9.20

11331

76481

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

8022

44569

1.76

307.65

1.3

27.1

38.2

iu/ml

6.11

2424

14149

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

30248

202818

2.69

307.65

8.8

7.1

78.1

78.2

u/l

0.15

28621

190735

(3007164) IgA [Mass/volume] in Serum or Plasma

9470

46778

2.06

307.65

1.5

1.4

2.4

g/l

0.03

5547

28730

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

11770

59937

2.08

307.65

2.6

2.1

3.0

2.9

mg/l

5.88

10042

51049

(3013512) EKG study

13782

72871

2.07

307.65

4.5

3.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

17005

95743

2.05

307.65

4.3

3.3

42.5

67.1

ng/l

2.00

11537

63806

(3013707) Erythrocyte sedimentation rate by Westergren method

29394

195533

2.56

307.65

5.2

3.8

11.8

12.0

mm/h

0.74

27179

181109

(3013115) Eosinophils [#/volume] in Blood

21442

134352

1.97

307.65

6.6

6.0

0.2

e9/l

0.89

19108

117597

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

31816

247110

1.95

307.65

6.8

5.5

40.0

39.6

mmol/mol

11.79

29161

229155

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

34557

269825

2.81

307.65

19.1

12.9

20.4

24.1

mg/l

87.85

29156

211391

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

3124

12214

2.38

307.65

2.6

2.3

—

(3022145) Colonoscopy Study observation

6385

27360

2.29

307.65

1.3

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

6384

32818

1.87

307.65

2.8

2.5

22.2

23.1

5.12

5343

28096

(3037467) Urinalysis macro (dipstick) panel - Urine

26777

180690

2.11

307.65

5.4

4.0

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

3430

14688

2.18

307.65

3.9

3.6

1.4

1.8

mmol/l

6.38

2599

10809

(40768804) Tissue Pathology biopsy report

16362

107790

1.61

307.65

2.2

2.1

—

(3037522) Nuclear Ab [Titer] in Serum

6798

34259

1.93

307.65

1.4

1.3

588.7

523.3

titre

1.78

1533

6824

(3019069) Monocytes/100 leukocytes in Blood

19837

122251

1.93

307.65

7.0

6.2

8.5

8.6

5.23

18480

114662

(3019309) Folate [Moles/volume] in Red Blood Cells

9013

44436

2.05

307.65

1.9

1.7

1101.0

1182.1

nmol/l

13.57

6720

33520

(42870588) Differential panel, method unspecified - Blood

15649

87236

2.01

307.65

6.3

5.9

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

22885

132141

2.38

307.65

6.2

6.0

10.7

11.5

umol/l

16.81

21672

125163

(3002030) Lymphocytes/100 leukocytes in Blood

20222

125808

1.92

307.65

6.8

6.0

28.2

28.0

0.65

18689

117418

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3584

15413

2.17

307.65

4.0

3.6

5.1

kpa

1.42

3312

14235

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

20682

127944

1.97

307.65

7.5

6.4

1.2

mmol/l

4.15

17306

107640

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

32550

246225

2.34

307.65

5.8

4.5

1.9

2.1

mu/l

5.12

29741

226083

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

8206

48563

1.64

298.34

4.5

3.5

348.3

554.2

ng/l

3.36

6051

37159

(3026008) Bacteria identified in Urine by Culture

11756

75746

1.55

297.29

3.5

3.0

—

(3027945) Reticulocytes/100 erythrocytes in Blood

5099

26544

1.81

295.16

2.5

2.6

1.8

1.7

0.96

4371

23622

(3012095) Magnesium [Moles/volume] in Serum or Plasma

7109

40659

1.68

294.77

3.5

3.4

0.8

mmol/l

2.84

6584

37871

(3009261) Glucose [Presence] in Urine by Test strip

18462

131063

1.49

292.14

4.3

3.5

0.0

estimate

0.36

3294

24261

(3035350) Ketones [Presence] in Urine by Test strip

18225

129288

1.49

287.61

4.3

3.4

0.0

estimate

0.27

3281

24469

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

390

406

8.59

287.48

1.0

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

35026

289089

2.19

284.72

21.3

15.1

78.9

76.6

umol/l

23.78

35005

288956

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

4487

22697

1.85

284.23

2.4

2.1

0.2

g/l

2.57

4173

21102

(40761511) CBC panel - Blood by Automated count

34454

282667

2.03

284.16

18.6

12.1

—

(3015736) pH of Urine

14618

99669

1.49

277.63

3.9

3.2

5.8

5.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2821

12251

2.12

276.36

1.1

1.0

—

(3023368) Bacteria identified in Blood by Culture

10705

68578

1.54

272.60

4.6

4.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

3100

14032

2.04

271.81

1.9

1.3

g/l

0.20

2799

12800

(3021601) Nitrite [Presence] in Urine by Test strip

18164

129793

1.47

269.01

5.8

4.6

0.0

estimate

0.05

3409

24930

(3026493) Urate [Moles/volume] in Serum or Plasma

10773

69555

1.52

262.42

2.9

2.5

3280.5

4445.8

umol/l

2.72

9172

60593

(3003458) Phosphate [Moles/volume] in Serum or Plasma

5802

32322

1.70

262.12

6.4

5.7

1.0

mmol/l

1.31

5392

30091

(3017732) Neutrophils [#/volume] in Blood

3616

17541

1.91

259.32

3.0

2.8

4.0

4.1

e9/l

2.44

2548

13757

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

2385

10009

2.19

254.19

2.0

1.9

—

(3023520) Reticulocytes [#/volume] in Blood

3887

19661

1.84

243.85

2.6

68.9

69.2

e9/l

0.24

3073

14663

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

31819

257274

1.65

239.44

4.6

3.8

1.3

mmol/l

26.35

28904

236646

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

3648

18249

1.85

236.70

4.0

3.8

92.8

89.5

ng/l

1.01

3054

15779

(3022217) INR in Platelet poor plasma by Coagulation assay

5720

32595

1.65

234.46

23.3

23.9

1.3

1.4

inr

1.31

970

4548

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

33345

273343

1.75

233.24

5.7

4.7

2.7

2.8

mmol/l

34.28

30455

252766

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1430

4970

2.61

232.10

1.4

1.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

32881

268603

1.71

231.41

5.1

4.3

4.6

4.7

mmol/l

35.76

30245

249685

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

32667

266567

1.68

228.34

5.2

4.2

1.4

1.5

mmol/l

27.45

29856

246698

(3003327) Ova and parasites identified in Stool by Light microscopy

1959

7945

2.25

226.33

1.8

1.7

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

991

2861

3.12

226.29

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

982

2821

3.14

226.11

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

981

2818

3.14

225.90

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

979

2817

3.13

224.79

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

987

2858

3.11

224.23

1.4

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1004

2939

3.08

223.93

1.4

—

(3000494) Fungus identified in Specimen by Culture

5255

29679

1.66

221.85

1.6

1.4

—

(3018418) pH of Serum or Plasma

11380

76367

1.46

220.17

4.5

4.0

7.4

0.39

2230

14873

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2157

9197

2.14

219.98

1.9

1.8

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

4978

28022

1.66

212.02

3.6

4.4

233.9

245.5

u/l

9.18

4625

26590

(3025941) Bacteria identified in Stool by Culture

2937

14214

1.90

210.03

1.3

1.2

—

(3020682) Albumin/Creatinine [Ratio] in Urine

11835

80856

1.43

204.35

4.2

3.9

9.5

8.5

mg/mmol

1.14

7111

50939

(3004616) Nuclear Ab [Presence] in Serum

942

2820

3.01

202.02

1.3

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

4154

22597

1.71

200.45

2.8

2.3

35.9

45.9

u/l

1.56

3523

19288

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

7218

44934

1.52

198.94

1.6

1.5

—

(3009508) Creatinine [Moles/volume] in Urine

11901

82004

1.42

193.25

3.4

3.2

7.4

7.7

mmol/l

9.81

9699

69100

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

1660

6712

2.25

192.58

1.3

1.2

27.0

38.3

u/ml

1.13

412

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

935

2875

2.93

191.20

2.4

1.9

23.4

27.2

mg/l

1.05

217

790

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

3374

17563

1.77

189.77

2.5

2.3

29.3

24.1

au/ml

1.02

146

1064

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1559

6181

2.29

189.46

1.3

1.2

8.2

7.9

u/ml

0.07

278

945

(3012516) Albumin [Mass/volume] in Urine

11221

76858

1.42

186.96

3.4

3.2

540.3

384.9

mg/l

2.13

6729

48320

(3007461) Platelets [#/volume] in Blood

35835

303221

2.17

185.87

28.4

19.0

254.1

251.7

e9/l

10.27

35258

294919

(3018095) Leukocytes [#/volume] in Urine

13089

92220

1.40

184.58

4.4

3.5

75.2

102.2

e6/l

4.19

9731

64643

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

1528

6107

2.27

182.09

1.3

1.2

6.9

6.5

u/ml

0.05

183

594

(3035941) MCH [Entitic mass]

35835

303426

2.15

181.73

28.2

18.9

30.2

30.3

14.84

35452

299105

(3033658) Prothrombin time (PT) actual/Normal

9862

66287

1.43

181.34

4.5

3.7

91.8

90.6

5.09

9610

64665

(3024731) MCV [Entitic volume]

35837

303470

2.15

181.31

28.2

18.9

90.9

91.0

1.23

35456

299127

(3010813) Leukocytes [#/volume] in Blood

35841

303540

2.15

180.85

28.4

19.0

6.8

6.7

e9/l

9.23

35172

294332

(3026361) Erythrocytes [#/volume] in Blood

35836

303493

2.15

180.62

28.3

19.0

4.5

e12/l

41.73

35174

294309

(3000963) Hemoglobin [Mass/volume] in Blood

35839

303580

2.15

179.57

28.5

19.1

134.4

136.0

g/l

91.37

35452

299265

(3026782) Osmolality of Urine

7771

50021

1.47

179.29

3.2

2.7

533.4

549.2

mosm/kgh2o

7.18

6607

42601

(3000492) Spirometry study

4381

24832

1.64

179.22

1.6

1.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

3130

16271

1.77

176.23

2.1

2.4

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1593

6570

2.20

175.83

1.1

5.6

5.4

u/ml

0.04

140

897

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

3070

16006

1.76

170.86

1.3

45.9

51.0

au/ml

0.41

728

(3002582) Erythrocytes [#/volume] in Urine

11323

78765

1.39

168.19

3.8

3.1

74.3

94.1

e6/l

0.86

9035

59792

(3000850) Epithelial cells [#/volume] in Urine

8236

54174

1.44

167.98

2.9

2.5

5.1

5.5

e6/l

2.26

7234

47220

(3007853) Bacteria identified in Skin by Aerobe culture

5042

30028

1.56

166.66

1.9

1.7

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1285

4988

2.33

163.73

1.3

1.2

7.0

6.3

u/ml

0.08

101

363

(3020630) Protein [Mass/volume] in Serum or Plasma

3629

20033

1.67

163.66

2.3

2.6

66.6

g/l

0.13

3255

18277

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1722

7574

2.06

160.74

1.8

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

1275

4976

2.31

160.41

1.3

1.2

9.5

10.1

u/ml

0.04

(3042936) Bacteria identified in Isolate by Culture

5821

36053

1.51

160.09

2.2

1.9

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

13921

100697

1.36

159.92

4.5

3.6

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

2138

10283

1.89

154.22

1.7

1.6

g/l

0.76

1813

8740

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

1785

8091

2.00

153.23

3.0

2.6

—

(3007566) Smooth muscle Ab [Titer] in Serum

1502

6473

2.10

147.83

1.2

96.4

130.5

titre

1.04

129

581

(3034770) Mitochondria Ab [Titer] in Serum

1487

6404

2.10

146.59

1.2

806.4

969.9

titre

0.46

195

(3038026) Centromere Ab [Units/volume] in Serum

633

1817

3.12

145.75

1.2

32.4

56.6

u/ml

1.05

(40758558) Short blood count panel - Blood

9577

66084

1.38

144.50

6.5

7.0

—

(3030467) Casts [#/volume] in Urine by Automated count

10301

72128

1.37

141.19

3.6

3.0

0.3

0.4

e6/l

6.60

8009

53708

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

614

1773

3.10

139.96

1.2

67.5

74.7

u/ml

0.20

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

614

1779

3.09

139.16

1.2

44.5

48.4

u/ml

0.15

128

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

439

1027

3.82

138.44

1.1

7.1

8.6

u/ml

0.38

177

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

21862

171023

1.32

137.68

3.2

2.9

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

978

3632

2.42

137.44

1.2

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

3573

20499

1.60

136.68

3.2

2.8

171.3

200.5

ng/l

3.82

3211

18707

(36304419) Bacteria [Presence] in Urine

10021

70241

1.36

135.17

3.6

3.0

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2660

14279

1.70

131.94

1.8

1.6

—

(3019150) Specific gravity of Urine by Refractometry

8179

55734

1.38

130.84

4.7

3.8

1.0

kg/l

0.43

1531

8011

(3020961) Endomysium IgA Ab [Titer] in Serum

2243

11531

1.77

129.72

1.1

297.3

209.6

titre

0.48

295

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

580

1700

3.05

128.90

1.2

14.0

7.8

u/ml

0.52

108

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

3607

21019

1.58

128.69

2.6

2.2

5.8

7.6

ug/l

8.43

3031

18378

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1994

9975

1.81

126.31

1.3

1.2

0.7

u/ml

0.78

170

886

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

6987

46607

1.40

126.22

2.8

3.0

2.4

2.5

mmol/l

5.86

5924

40871

(3041096) Erythrocytes [Presence] in Urine by Automated

10013

70823

1.34

125.24

3.9

3.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

2078

10563

1.79

124.75

1.9

2.0

39.5

39.2

u/l

0.23

1843

9385

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

4263

26055

1.51

121.95

3.2

4.2

17.5

27.3

ug/l

1.69

3339

20985

(3018677) aPTT in Platelet poor plasma by Coagulation assay

6005

39286

1.42

120.53

2.1

29.7

29.8

1.12

5777

38155

(3020779) Urea [Moles/volume] in Serum or Plasma

3660

21913

1.53

114.92

8.5

7.1

9.8

9.7

mmol/l

0.36

3491

20841

(3009445) Proteinase 3 Ab [Units/volume] in Serum

2075

10829

1.74

113.45

1.4

1.6

11.1

16.6

u/ml

0.75

306

(3045414) Leukocytes [Presence] in Urine

2143

11358

1.71

110.77

1.9

1.8

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

5022

32293

1.44

109.84

7.5

6.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

498

1467

3.03

109.75

1.3

1.2

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1107

4756

2.09

109.50

1.2

1.3

117.8

142.2

titre

—

110

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1916

9882

1.76

109.09

1.1

1.4

7.5

u/ml

1.22

141

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

499

1477

3.02

109.07

1.3

1.2

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

950

3851

2.22

108.90

1.5

1.6

0.6

0.8

g/l

5.91

699

2894

(3017143) Hepatitis C virus Ab [Presence] in Serum

4468

28151

1.46

108.84

1.7

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

4395

27607

1.46

108.76

2.0

1.7

—

(3045424) Erythrocytes [Presence] in Urine

1006

4184

2.16

108.20

1.4

1.5

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1573

7706

1.84

106.28

1.8

1.6

1.2

g/l

0.40

1485

7345

(3026389) Candida sp identified in Specimen by Organism specific culture

862

3396

2.28

105.81

1.5

1.3

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1533

7478

1.85

104.98

1.8

1.6

0.2

g/l

2.24

1440

7104

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1392

6593

1.90

104.46

1.3

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1680

8455

1.80

103.90

2.1

2.3

402.5

524.3

ug/l

0.93

1578

7910

(40760892) CBC W Ordered Manual Differential panel - Blood

8320

58610

1.33

103.05

4.8

4.3

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

539

1722

2.80

102.69

1.3

0.8

1.3

u/ml

0.97

266

753

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

4824

31204

1.42

101.39

1.9

1.7

1.5

1.4

11.46

4136

27574

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1662

8405

1.79

101.08

1.6

283.4

274.7

titre

0.04

369

(3022621) pH of Urine by Test strip

2856

16634

1.56

100.89

3.4

2.8

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

6070

41082

1.37

97.12

3.4

2.8

2.9

2.8

e6/l

0.18

3508

21916

(3011397) Hemoglobin [Presence] in Urine by Test strip

8500

60539

1.32

96.26

4.2

3.5

—

(3003396) Base excess in Arterial blood by calculation

4451

28623

1.43

96.23

7.5

7.0

1.1

mmol/l

0.22

3552

22576

(4062490)

665

2437

2.44

96.14

1.4

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

4450

28640

1.43

95.73

7.5

7.0

5.0

5.1

kpa

4.97

4222

27380

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

4329

27736

1.43

95.45

2.0

1.7

—

(3012544) pH of Venous blood

3797

23739

1.46

95.38

4.6

3.9

7.4

0.44

116

(3027801) Oxygen [Partial pressure] in Arterial blood

4445

28623

1.43

95.31

7.5

7.0

11.9

12.6

kpa

16.37

4217

27344

(3028192) IgG subclass 2 [Mass/volume] in Serum

663

2439

2.43

95.06

1.4

2.9

g/l

0.30

459

1691

(40768443) Skin Pathology biopsy report

2073

11331

1.66

95.02

1.2

—

(3002032) Base excess in Venous blood by calculation

3669

22805

1.47

94.95

4.7

3.9

1.8

1.9

mmol/l

0.48

3030

18660

(3024139) IgG subclass 3 [Mass/volume] in Serum

662

2439

2.43

94.60

1.4

0.4

g/l

1.57

462

1692

(3027135) IgG subclass 1 [Mass/volume] in Serum

662

2441

2.43

94.43

1.4

6.3

6.8

g/l

3.14

458

1691

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

1442

7142

1.82

93.88

1.4

1.3

—

(3037121) Protein [Mass/volume] in Urine

1648

8520

1.75

92.76

3.0

3.3

0.3

g/l

0.30

588

3858

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

2758

16236

1.54

92.55

3.1

3.4

4.5

pmol/l

1.02

2381

14521

(3014765) Yersinia sp identified in Stool by Organism specific culture

1421

7054

1.81

91.80

1.2

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1218

5759

1.90

91.76

1.8

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

1422

7073

1.81

91.26

1.2

—

(3029937) Albumin [Presence] in Urine by Test strip

9664

70466

1.29

90.72

4.8

3.8

0.0

estimate

0.58

3341

23912

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1407

6992

1.81

90.56

1.2

1.1

—

(3016502) Oxygen saturation in Arterial blood

4000

25532

1.43

89.62

7.8

7.4

95.5

95.7

1.02

3855

24601

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1378

6832

1.82

89.36

1.5

19.1

14.2

iu/ml

0.55

176

(3014111) Lactate [Moles/volume] in Serum or Plasma

3513

21916

1.46

88.86

7.1

6.9

1.3

mmol/l

0.37

3366

21130

(3021447) Carbon dioxide [Partial pressure] in Venous blood

3644

22915

1.45

88.39

4.6

3.9

5.8

kpa

1.33

3536

22263

(3023419) Bacteria identified in Sputum by Culture

727

2900

2.24

86.62

2.9

2.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

765

3135

2.19

85.34

1.1

1.5

g/l

0.51

684

2844

(3009542) Hematocrit [Volume Fraction] of Blood

29779

248482

1.30

85.25

19.4

13.9

39.3

40.0

26.23

20028

182255

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

6379

44271

1.33

85.14

3.1

2.7

1.0

1.2

e6/l

1.68

3805

24926

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

2466

14434

1.55

84.64

1.6

1.5

—

(3044889) 12 lead EKG panel

23315

189018

1.25

84.51

4.3

3.6

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1711

9170

1.68

84.35

2.0

2.3

7.4

g/l

0.09

1201

6911

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1085

5077

1.92

84.31

1.3

1.2

40.7

44.3

u/ml

0.30

108

499

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1706

9142

1.68

84.14

2.0

2.3

3.7

3.8

g/l

2.21

1124

6595

(3014576) Chloride [Moles/volume] in Serum or Plasma

4742

31507

1.38

83.82

7.6

6.8

104.2

104.5

mmol/l

3.40

4641

30807

(3017181) Myelocytes/100 leukocytes in Blood

3517

22188

1.45

83.58

4.2

4.1

0.9

1.0

0.57

1056

6065

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1705

9165

1.68

83.09

2.0

2.3

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1329

6675

1.79

82.49

1.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1099

5219

1.89

81.64

1.5

1.6

—

(3019060) Gas panel - Arterial blood

2702

16311

1.50

80.17

5.0

4.7

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

2837

17317

1.49

79.71

1.2

111.2

145.5

iu/ml

5.13

944

6642

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

866

3829

2.03

79.18

1.3

1.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

3350

21180

1.44

78.41

4.3

4.1

0.1

2.27

1004

5638

(3044927) Protein electrophoresis panel - Urine

578

2190

2.36

77.66

1.2

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1146

5609

1.83

77.41

1.8

1.6

—

(3042631) Mycobacterium sp identified in Specimen

770

3302

2.09

76.47

2.9

2.5

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

718

3014

2.13

75.38

1.2

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

1003

4749

1.89

75.17

2.8

2.4

32.6

33.0

umol/l

0.21

847

3992

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1596

8655

1.66

75.08

2.0

2.3

3.0

3.1

g/l

2.64

1158

6769

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1578

8546

1.66

74.61

1.9

2.3

10.1

10.3

g/l

0.46

1263

7177

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

1308

6733

1.75

74.55

1.9

2.1

11.0

10.9

mg/l

0.17

1187

6300

(4015189)

242

577

3.73

74.49

2.4

2.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

783

3413

2.05

74.44

1.3

0.6

1.2

nmol/l

1.05

756

3294

(3002179) Metamyelocytes/100 leukocytes in Blood

3198

20245

1.44

74.12

4.0

3.9

0.6

0.7

1.01

814

4386

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

510

1883

2.42

72.61

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

9510

70743

1.26

72.24

1.7

1.6

1.4

mmol/l

10.66

7958

59274

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

775

3413

2.03

71.65

1.3

0.3

0.2

nmol/l

0.16

230

(4146454)

645

2652

2.17

71.39

2.8

2.7

—

(3049717) Cytology report of Urine Cyto stain

1721

9644

1.61

70.96

2.4

2.7

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

639

2648

2.16

69.35

3.6

3.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

372

1205

2.75

69.19

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

5145

35564

1.33

68.98

1.7

1.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

901

4238

1.90

68.88

1.6

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

2971

18817

1.43

68.42

4.1

3.3

4.7

4.6

kpa

0.37

2872

18208

(3017354) Segmented neutrophils/100 leukocytes in Blood

592

2394

2.21

68.29

3.5

3.3

58.2

58.3

0.01

390

1530

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1002

4905

1.83

67.61

6.8

5.3

664.9

2075.7

iu/ml

0.80

174

682

(4024509)

562

2238

2.24

67.30

1.7

1.6

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

393

1332

2.63

66.95

2.7

2.8

23.8

25.9

ug/l

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1360

7286

1.68

66.94

1.3

—

(40761535) Cells panel - Urine sediment

3238

20910

1.41

66.77

3.8

3.4

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

1205

6254

1.73

66.65

3.0

3.2

24.6

24.7

mmol/l

0.29

1050

5506

(3002173) Hemoglobin [Mass/volume] in Arterial blood

3594

23648

1.38

66.28

8.4

7.8

121.5

122.2

g/l

1.32

3467

22796

(3025159) Blasts/100 leukocytes in Blood

3116

20058

1.41

65.38

4.2

4.1

0.2

0.05

858

4793

(3008898) HLA-B27 [Presence]

1516

8415

1.62

64.90

1.1

—

(3004809) Band form neutrophils/100 leukocytes in Blood

847

3985

1.90

64.71

3.5

3.3

1.3

1.4

0.37

651

3100

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1396

7599

1.65

64.60

1.7

1.6

10.1

4.9

iu/ml

0.47

283

1596

(3003181) Sodium [Moles/volume] in Urine

849

4004

1.90

64.39

1.5

1.4

64.0

63.5

mmol/l

0.11

674

3183

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1693

9694

1.57

63.60

2.1

2.0

2.2

ug/l

0.29

1460

8545

(46235355) HIV 1 and 2 tests - Meaningful Use set

5994

42718

1.29

63.57

1.9

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

786

3638

1.93

63.07

1.1

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

1423

7835

1.63

62.92

2.1

2.5

0.7

0.9

g/l

1.58

1168

6749

(3047181) Lactate [Moles/volume] in Blood

1408

7733

1.64

62.89

5.8

5.7

1.3

mmol/l

0.03

1258

6847

(3030981) Hyaline casts [#/volume] in Urine by Automated count

2221

13516

1.48

62.84

3.0

2.7

0.2

0.3

e6/l

0.80

2167

13122

(3000991) Gas panel - Venous blood

3234

21102

1.39

62.53

8.9

8.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

2073

12472

1.50

62.02

1.4

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

699

3126

2.00

61.94

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

782

3636

1.92

61.91

1.3

1.2

—

(3016244) Insulin [Units/volume] in Serum or Plasma

397

1408

2.51

61.68

2.9

3.3

27.5

27.3

mu/l

0.03

375

1321

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

358

1211

2.63

61.27

1.7

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

358

1211

2.63

61.27

1.7

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

358

1211

2.63

61.27

1.7

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

358

1211

2.63

61.27

1.7

2.0

—

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

419

1539

2.43

60.41

2.7

3.5

93.7

141.9

nmol/l

2.55

408

1518

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

454

1734

2.33

60.00

1.1

284.3

461.8

mg/l

0.53

387

1574

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

775

3636

1.91

59.73

1.5

1.4

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

723

3332

1.94

58.77

1.6

1.4

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

2472

15562

1.44

58.49

7.4

6.8

24.5

24.6

mmol/l

1.00

2306

14516

(3017315) Amylase [Enzymatic activity/volume] in Urine

356

1238

2.56

57.65

1.2

281.2

330.3

u/l

0.24

323

1164

(3004119) Hemoglobin [Mass/volume] in Venous blood

2358

14785

1.44

56.97

4.0

3.3

128.0

130.0

g/l

4.25

2288

14462

(21494755) Public health laboratory ask at order entry panel

2237

27707

0.70

56.83

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

4215

29056

1.32

56.65

1.7

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1735

10252

1.52

56.46

5.3

4.8

1.7

0.16

1630

9623

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2191

13574

1.46

56.41

9.5

9.4

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1706

10075

1.52

55.65

5.3

4.9

0.9

0.40

1607

9445

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

492

2012

2.18

55.28

1.6

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

492

2012

2.18

55.28

1.6

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

492

2012

2.18

55.28

1.6

1.7

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

323

1097

2.62

54.90

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

323

1097

2.62

54.90

1.5

1.4

—

(4094501)

1277

7083

1.62

54.76

1.1

—

(3006462) Nitrate [Presence] in Urine

327

1119

2.60

54.74

4.2

2.7

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

1929

11725

1.48

54.73

4.2

3.3

25.2

25.3

mmol/l

0.81

1874

11365

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

259

787

2.93

54.31

1.3

1.1

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

962

4967

1.73

54.18

2.9

3.4

566.5

938.5

u/ml

0.44

857

4525

(3032057) Clostridioides difficile [Presence] in Stool

177

430

3.66

53.19

1.9

1.7

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

599

2684

1.99

52.84

2.8

3.3

7.2

7.7

nmol/l

0.05

573

2613

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

1342

7597

1.59

52.84

2.9

3.4

49.9

42.1

mg/l

0.34

1092

6101

(4211845)

344

1231

2.49

52.53

4.1

2.6

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

1342

7616

1.58

52.28

2.9

3.4

48.1

56.8

mg/l

0.87

1093

6109

(3030905) Polymorphonuclear cells [#/volume] in Blood

984

5165

1.71

52.22

3.5

3.3

4.1

e9/l

0.06

979

5156

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

1274

7145

1.60

52.18

1.8

2.3

38.0

37.8

g/l

0.63

1035

6175

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

520

2236

2.07

51.38

3.7

—

(3021589) Normoblasts [#/volume] in Blood

14949

119227

1.18

51.02

11.2

9.2

0.0

e9/l

0.55

12497

97679

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

11031

85700

1.20

50.64

5.2

4.8

2.6

3.3

ug/l

2.82

9863

77085

(3002256) Pathology report gross observation

4948

35328

1.28

50.49

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

1301

7390

1.58

50.47

2.9

3.4

8.2

4.0

ratio

0.33

605

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

582

2629

1.98

50.20

1.2

62.5

62.4

u/l

0.01

350

1795

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

3840

26547

1.31

50.14

3.7

3.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

569

2553

1.99

50.03

1.7

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

134

278

4.28

49.94

1.7

1.8

38.6

38.7

pmol/l

0.00

107

229

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

832

4229

1.76

49.52

1.8

1.7

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

386

1496

2.30

49.41

1.4

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1088

5966

1.63

48.85

4.3

3.5

8.4

8.3

kpa

0.96

1000

5556

(3006184) Hemoglobin [Mass/volume] in Capillary blood

1063

5803

1.64

48.58

2.3

2.2

130.2

130.6

g/l

0.15

748

4284

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

598

2762

1.93

48.36

1.1

1.4

2.0

iu/ml

0.53

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

281

950

2.63

48.27

1.8

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

281

951

2.63

48.17

1.8

2.1

—

(3052851) Hemolysis interference index of Serum or Plasma

1322

7624

1.56

47.99

3.4

3.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

663

3180

1.86

47.79

1.5

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

378

1474

2.28

47.72

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

1103

6104

1.62

47.72

1.7

1.6

10418.0

13692.2

e6/l

2.31

802

4455

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

527

2341

2.01

47.68

1.8

1.7

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

405

1630

2.21

47.41

2.3

2.8

0.2

e9/l

0.70

367

1392

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

282

966

2.60

47.19

1.8

2.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

579

2669

1.94

47.11

1.7

1.6

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

2921

19602

1.35

46.71

2.4

2.1

12.8

12.4

nmol/l

1.42

2534

17410

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

504

2220

2.02

46.69

3.0

2.7

—

(3011412) CD3 cells [#/volume] in Blood

536

2417

1.98

46.49

2.2

2.6

1.3

1.1

e9/l

1.73

285

1481

(4035726)

3401

23353

1.32

46.42

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

696

3422

1.82

46.35

1.1

2.6

3.0

u/ml

0.22

241

1762

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

773

3926

1.76

46.15

1.1

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

908

4824

1.68

46.09

1.3

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1787

11112

1.45

44.92

3.4

2.8

0.7

0.34

1741

10616

(40761536) Microorganisms panel - Urine sediment

3292

22614

1.32

44.71

4.8

3.8

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3348

23057

1.31

44.65

2.1

1.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

878

4663

1.68

44.63

1.6

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3670

25623

1.30

44.20

2.2

2.0

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

637

3097

1.84

44.02

1.4

1.2

81.3

48.6

u/ml

2.51

186

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

898

4823

1.66

43.75

1.1

1.7

1.6

u/ml

0.09

362

1920

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1884

11887

1.42

43.72

5.0

4.3

24.1

24.2

mmol/l

0.10

1708

10680

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

2063

13227

1.40

43.70

9.2

9.1

24.5

24.4

mmol/l

1.24

1915

12363

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2717

18213

1.35

43.65

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

761

3912

1.74

43.57

1.1

15.5

11.9

au/ml

0.49

248

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

407

1700

2.13

43.47

2.3

2.7

562.4

531.3

e6/l

0.38

365

1399

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

406

1698

2.13

43.22

1.9

1.6

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

1199

6932

1.55

43.02

1.9

2.3

0.0

g/l

0.15

1074

6367

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

739

3797

1.74

42.40

3.2

2.8

645.2

5854.2

u/ml

1.12

206

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

269

952

2.51

42.17

2.1

1.9

86.9

136.5

umol/l

3.07

147

475

(44816559) Phosphatidylethanol [Mass/volume] in Blood

830

4413

1.68

42.03

1.4

1.3

—

(1616796) Gas panel - Central venous blood

1026

5754

1.60

42.02

3.7

3.6

—

(3021901) Oxygen saturation in Capillary blood

857

4596

1.67

42.00

2.9

—

(44806118)

553

2624

1.88

41.29

1.8

1.5

—

(44790049)

553

2625

1.88

41.24

1.8

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2385

15806

1.36

41.21

8.0

7.0

24.9

24.8

mmol/l

0.73

2367

15655

(44790047)

553

2626

1.88

41.19

1.8

1.5

—

(44790048)

553

2626

1.88

41.19

1.8

1.5

—

(3021788) Differential panel - Synovial fluid

862

4661

1.65

40.92

1.6

1.5

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

961

5349

1.61

40.62

1.7

1.5

—

(40760888) Immunoglobulin light chains.free panel - Serum

1008

5676

1.59

40.58

3.0

3.5

—

(3008295) Osmolality of Serum or Plasma

495

2292

1.92

39.82

1.6

1.4

278.5

279.6

mosm/kgh2o

0.45

388

1778

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

219

728

2.67

39.00

2.5

3.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

1164

6832

1.53

38.99

1.5

1.4

—

(3010421) pH of Blood

1158

6793

1.53

38.88

4.2

3.8

7.4

0.18

996

5745

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

1107

6443

1.54

38.54

1.3

1.4

491.5

548.8

mg/l

2.88

1035

6177

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

436

1957

1.98

38.41

1.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

624

3147

1.77

38.24

2.6

451.6

959.9

u/ml

0.54

616

3024

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

232

803

2.57

38.13

1.9

1.6

50858.6

19118.9

u/ml

0.36

105

(3037756) Immunofixation for Serum or Plasma

905

5042

1.60

38.12

1.8

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

1097

6389

1.54

38.08

1.9

2.4

0.0

g/l

0.27

974

5846

(3006270) Folate [Moles/volume] in Blood

435

1964

1.97

37.70

1.3

1.1

337.9

374.8

nmol/l

3.40

376

1636

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1708

10885

1.41

37.38

5.0

3.8

49.4

48.1

1.35

1689

10767

(3039000) Anion gap in Blood

972

5534

1.57

37.34

6.8

6.5

11.3

11.2

mmol/l

0.51

891

4983

(3018572) Chloride [Moles/volume] in Blood

972

5535

1.57

37.31

6.8

6.6

104.9

105.2

mmol/l

0.95

891

4984

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

342

1418

2.15

37.30

1.4

5.1

5.9

u/l

1.81

283

1211

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

892

4979

1.60

37.28

1.5

1.4

14.0

20.0

u/ml

0.89

(3010375) cycloSPORINE [Mass/volume] in Blood

264

984

2.39

37.08

30.4

28.1

113.3

116.6

ug/l

0.34

217

841

(3035637) Corticotropin [Mass/volume] in Plasma

619

3143

1.76

37.07

1.5

—

(3000330) Specific gravity of Urine by Test strip

1924

12534

1.38

36.94

4.0

3.3

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

391

1712

2.03

36.94

1.7

1.5

67.6

71.1

umol/l

0.38

136

(3010503) CD19 cells [#/volume] in Blood

356

1509

2.10

36.69

2.2

2.7

0.3

e9/l

0.03

348

1464

(3013005) Retinol [Moles/volume] in Serum or Plasma

257

951

2.40

36.69

1.9

1.8

2.0

umol/l

0.03

238

896

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1402

8668

1.45

36.27

2.9

3.5

370.7

2254.9

u/ml

1.75

1182

7457

(3020191) Ethanol [Moles/volume] in Serum or Plasma

433

1982

1.95

36.09

1.8

1.4

1.3

promille

0.65

340

1504

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

3091

21647

1.29

35.98

4.2

3.7

1.2

mmol/l

0.87

2767

18799

(3019420) Tryptase [Mass/volume] in Serum or Plasma

315

1283

2.18

35.95

1.4

1.5

7.0

8.3

ug/l

0.91

293

1158

(3013290) Carbon dioxide [Partial pressure] in Blood

1014

5887

1.54

35.72

4.2

3.8

5.0

kpa

0.17

996

5743

(3012501) Base excess in Blood by calculation

1013

5886

1.54

35.55

4.2

3.8

2.5

mmol/l

0.03

703

3988

(3027315) Oxygen [Partial pressure] in Blood

1017

5917

1.54

35.48

4.2

3.9

8.7

8.6

kpa

0.45

999

5772

(3006653) Thiamine [Moles/volume] in Blood

291

1155

2.24

35.38

1.4

1.2

132.4

138.1

nmol/l

1.38

291

1155

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

1070

6299

1.52

35.35

1.9

2.4

0.0

g/l

0.00

970

5828

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

424

1943

1.94

35.24

1.2

1.1

55.0

55.6

u/ml

—

(3044290) Cell count panel - Cerebral spinal fluid

931

5322

1.56

35.15

1.3

1.5

—

(3014271) Vancomycin [Susceptibility]

295

1181

2.22

35.14

2.8

2.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

820

4558

1.61

34.89

1.3

286.1

264.8

u/ml

1.19

507

2906

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

883

5027

1.57

33.95

1.6

1.4

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

329

1397

2.10

33.80

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

310

1289

2.14

33.63

1.1

87.9

84.6

u/l

0.21

268

1004

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

159

487

2.90

33.10

1.2

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

350

1534

2.03

33.04

1.6

6.8

6.5

u/l

0.11

158

759

(3027923) C peptide [Moles/volume] in Serum or Plasma

306

1277

2.13

32.90

1.6

1.5

1.3

1.2

nmol/l

0.29

230

1001

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

708

3854

1.64

32.81

1.4

1.3

27.6

30.0

u/l

1.08

548

3176

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

308

1290

2.12

32.81

1.1

22.9

25.1

u/l

0.26

256

966

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

607

3186

1.70

32.35

1.6

1.5

53.5

57.8

1.78

394

2012

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

413

1936

1.90

32.13

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

219

802

2.43

32.06

1.7

1.3

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

171

555

2.74

32.00

1.7

1.5

0.4

ug/l

0.73

114

358

(3020717) Zinc [Moles/volume] in Serum or Plasma

283

1159

2.17

31.93

1.5

22.7

26.1

umol/l

1.10

261

1101

(3003888) Timothy IgE Ab [Units/volume] in Serum

779

4372

1.59

31.87

1.1

4.2

4.8

u/ml

0.49

371

2204

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

424

2015

1.87

31.63

2.3

2.2

19.3

17.9

nmol/l

2.02

392

1908

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

229

862

2.36

31.56

1.2

—

(44813793)

383

1762

1.93

31.53

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

410

1930

1.89

31.50

1.3

2.0

2.1

mmol/l

0.74

374

1795

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

194

677

2.55

31.46

1.1

6.8

11.2

u/ml

1.19

(3010726) Horse dander IgE Ab [Units/volume] in Serum

728

4043

1.61

31.14

1.1

1.5

2.2

u/ml

1.26

170

978

(3006922) Hepatitis E virus Ab [Presence] in Serum

365

1664

1.95

30.87

1.1

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

743

4173

1.59

30.33

1.1

0.9

1.1

u/ml

0.51

292

1746

(3026250) Tacrolimus [Mass/volume] in Blood

252

1007

2.22

30.24

35.2

34.6

7.3

ug/l

0.01

226

917

(3023430) Cat dander IgE Ab [Units/volume] in Serum

604

3229

1.67

30.08

1.1

3.5

4.8

u/ml

1.15

235

1305

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

721

4029

1.60

30.07

1.3

1.5

—

(40767503) Oxygen content in Capillary blood by calculation

937

5553

1.51

30.03

2.7

2.5

16.6

16.5

0.50

514

2835

(3020491) Glucose [Moles/volume] in Blood

385

1804

1.90

30.03

1.7

1.8

6.6

6.9

mmol/l

1.14

264

1291

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

957

5700

1.50

29.94

1.2

1.3

3.8

3.7

mmol/l

0.26

881

5384

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

187

658

2.52

29.84

1.2

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

242

957

2.25

29.78

1.9

1.7

27.5

29.9

umol/l

3.14

228

925

(3009214) Lutropin [Units/volume] in Serum or Plasma

1144

7072

1.45

29.63

1.4

10.5

10.6

u/l

0.13

908

5736

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

1190

7412

1.44

29.59

1.8

1.7

42.1

41.4

nmol/l

0.39

1145

7230

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

893

5257

1.52

29.55

1.9

198.0

197.6

pmol/l

0.03

848

4983

(40768441) Liver Pathology biopsy report

370

1733

1.90

28.92

1.4

1.3

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

152

490

2.75

28.87

1.3

1.2

—

(3048879) Bone marrow aspiration report

185

661

2.49

28.62

1.7

1.9

—

(3014007) Fractional oxyhemoglobin in Arterial blood

2293

15909

1.29

28.49

9.7

8.9

93.8

94.0

0.59

2284

15853

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

1031

6298

1.46

28.43

1.8

12.2

11.9

iu/l

0.01

364

2307

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

246

1000

2.19

28.34

2.3

2.4

—

(3051593) INR in Capillary blood by Coagulation assay

268

1131

2.11

28.09

7.6

10.5

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

209

798

2.33

27.96

1.3

1.2

111.5

111.3

0.02

186

713

(3014133) Dog dander IgE Ab [Units/volume] in Serum

631

3476

1.62

27.95

1.1

3.7

4.5

u/ml

0.25

247

1325

(3014051) Protein [Presence] in Urine by Test strip

948

5724

1.48

27.75

2.4

2.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

552

2955

1.66

27.39

1.7

1.8

7411.8

3079.4

titre

0.33

130

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

855

5069

1.51

27.38

2.0

1.7

0.9

0.8

nmol/l

1.74

683

4266

(3010838) Calcium [Moles/time] in 24 hour Urine

278

1203

2.05

27.28

1.6

5.5

5.7

mmol/24h

0.09

(3016650) Hepatitis A virus Ab [Presence] in Serum

699

3974

1.57

27.12

1.1

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1228

7813

1.41

27.12

2.3

2.2

4794.1

5170.2

u/l

0.16

383

3048

(1002224) Polysomnography panel

1672

11179

1.34

27.08

1.1

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

1298

8340

1.39

27.06

3.3

3.1

0.3

0.4

u/ml

0.82

720

4776

(3034274) Bile acid [Moles/volume] in Serum --fasting

493

2570

1.71

27.03

2.0

2.1

9.6

7.3

umol/l

0.83

350

1881

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

377

1821

1.84

26.82

2.4

2.7

755.1

706.5

e6/l

0.26

212

691

(3033923) Metanephrine [Moles/time] in 24 hour Urine

145

476

2.70

26.65

1.1

0.8

umol/24h

0.01

236

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

784

4594

1.52

26.55

1.6

1.5

114.2

112.2

u/ml

0.15

193

1021

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

343

1613

1.89

26.53

1.1

6.3

8.4

iu/ml

0.86

412

(3003129) Base excess in Capillary blood by calculation

164

577

2.52

26.25

1.8

1.7

1.0

0.6

mmol/l

0.52

154

547

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

254

1086

2.08

25.77

1.5

1.6

2.3

10.6

nmol/l

0.95

205

915

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

327

1530

1.90

25.71

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2952

21370

1.24

25.65

2.9

2.6

65.2

66.3

ml/min/173m2

0.73

1252

8277

(3028271) Lactate [Moles/volume] in Capillary blood

712

4122

1.54

25.51

2.1

1.8

1.7

mmol/l

0.12

702

4017

(3011985) Renin [Units/volume] in Plasma

620

3478

1.59

25.51

1.6

1.5

68.2

64.7

mu/l

0.16

546

3106

(3029634) Reagin Ab [Titer] in Serum by VDRL

620

3483

1.59

25.36

2.1

13.9

6.9

titre

0.46

102

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

327

1540

1.89

25.21

1.1

—

(3022806) Fractional oxyhemoglobin in Capillary blood

597

3333

1.60

25.08

2.0

1.8

90.2

89.7

1.59

590

3280

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

2256

15885

1.27

24.88

9.8

8.8

0.7

0.40

2239

15801

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

889

5418

1.46

24.86

1.4

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

386

1923

1.79

24.86

1.8

2.2

13.4

14.3

0.59

176

877

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

598

3348

1.59

24.83

1.8

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

591

3300

1.60

24.81

6.7

6.0

11.7

11.4

mg/l

0.89

540

3042

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

889

5420

1.46

24.81

1.4

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

214

872

2.18

24.59

1.3

1.2

0.3

g/l

0.94

178

692

(3001186) Copper [Moles/volume] in Serum or Plasma

152

534

2.53

24.45

1.2

1.3

17.4

16.8

umol/l

0.70

128

484

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

214

875

2.17

24.39

2.3

1.9

57.4

60.8

ug/l

0.25

209

852

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

2252

15914

1.27

24.10

9.7

8.7

1.4

0.38

2232

15820

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1084

6893

1.40

24.04

3.6

3.8

1.6

1.5

mg/l

4.21

997

6339

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

799

4802

1.48

23.99

3.3

3.1

—

(1175426) CD3 cells/100 lymphocytes in Blood

388

1958

1.76

23.94

1.8

2.2

73.7

72.3

0.98

379

1879

(3024928) Oxygen saturation in Venous blood

843

5136

1.46

23.63

3.8

3.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

438

2298

1.70

23.53

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

136

462

2.61

23.44

1.2

—

(3040151) Glucose [Moles/volume] in Capillary blood

523

2876

1.62

23.42

6.8

6.7

7.5

7.2

mmol/l

0.29

408

2370

(3027231) Wheat IgE Ab [Units/volume] in Serum

131

442

2.63

22.90

1.0

1.1

1.5

2.4

u/ml

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

297

1403

1.88

22.75

1.7

1.8

1.4

2.5

u/field

3.85

211

988

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

172

663

2.30

22.63

1.7

1.6

9.6

8.9

ug/l

1.49

172

663

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

308

1475

1.86

22.61

1.3

1.2

87.8

90.3

u/l

0.16

267

1293

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

663

3895

1.52

22.26

1.3

32.2

31.5

u/l

0.07

565

3391

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1028

6566

1.40

22.24

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1169

7630

1.37

22.17

1.8

1.7

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

298

1432

1.85

21.67

1.3

1.2

24.5

25.2

u/l

0.08

256

1232

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

189

773

2.17

21.60

2.0

9.1

9.3

mg/l

0.18

157

613

(3033705) Calcium.ionized [Moles/volume] in Venous blood

516

2887

1.59

21.56

2.9

2.3

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

151

565

2.37

21.29

1.2

322.4

293.4

pmol/l

0.35

107

420

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

450

2443

1.64

21.27

1.4

1.6

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

370

1914

1.72

20.99

1.2

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

3252

24255

1.21

20.93

1.4

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

369

1911

1.72

20.86

1.2

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

296

1437

1.83

20.85

1.1

6.8

5.3

nmol/l

0.22

294

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

369

1912

1.72

20.82

1.2

—

(3017704) Immunofixation for Urine

272

1288

1.88

20.73

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1898

1.71

20.59

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

366

1901

1.71

20.48

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

365

1896

1.71

20.42

1.2

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

198

849

2.07

20.08

1.5

1.4

15.0

pmol/l

0.02

163

710

(3042733) HLA Ab [Presence] in Serum

184

769

2.12

19.95

5.0

5.2

—

(3036489) Thrombin time

1424

9731

1.31

19.80

2.1

21.5

0.03

1219

8502

(3023511) Choriogonadotropin [Units/volume] in Urine

637

3815

1.49

19.56

1.4

1.3

—

(21494815) CD4 cells/100 lymphocytes in Specimen

412

2242

1.63

19.35

1.9

2.3

40.7

39.7

0.17

277

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

555

3243

1.52

19.19

1.4

1.3

293.3

282.9

pmol/l

0.31

409

2539

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

8490

68497

1.13

19.04

4.4

4.2

21.8

22.0

0.49

3955

32960

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

326

1678

1.73

18.89

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

688

4213

1.45

18.88

1.1

1.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

429

2375

1.61

18.81

1.1

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

164

671

2.17

18.80

1.1

3.2

8.6

u/ml

0.46

378

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

493

2821

1.55

18.76

1.9

1.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

312

2.76

18.69

2.4

1.8

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

113

394

2.54

18.59

1.3

1.4

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

493

2827

1.55

18.59

1.1

1.0

0.5

u/ml

0.11

118

594

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

347

1826

1.69

18.56

1.9

2.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

5332

41797

1.15

18.56

1.5

1.4

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

363

1935

1.67

18.50

1.2

190.0

176.1

titre

0.12

327

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

362

1930

1.67

18.44

1.2

311.4

140.9

titre

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

1103

7357

1.34

18.22

2.5

2.6

187.7

187.5

0.03

1012

6982

(21494434) Karyotype in Bone marrow

378

2048

1.64

18.10

1.2

1.1

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

292

1480

1.75

17.90

1.3

35.8

75.5

titre

2.06

128

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

298

1521

1.74

17.83

1.3

464.4

370.4

titre

0.12

114

(3018405) Lactate [Moles/volume] in Arterial blood

1278

8740

1.31

17.70

4.5

4.0

1.4

mmol/l

0.04

1250

8593

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1936

13932

1.24

17.66

2.8

3.5

42.0

54.9

u/ml

1.49

1853

13483

(3016038) Potassium [Moles/volume] in Urine

301

1547

1.73

17.58

1.3

1.2

33.5

34.7

mmol/l

0.46

256

1329

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

216

1004

1.91

17.52

1.5

1.6

1825344.9

1839351.1

iu/ml

0.01

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

350

1876

1.66

17.50

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

884

5740

1.37

17.40

1.3

1.5

31.6

29.6

e6/l

0.05

688

4444

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

622

3797

1.46

17.39

1.3

1.2

3.5

3.8

u/ml

0.25

276

1657

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

455

2603

1.55

17.38

2.5

2.4

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

884

5746

1.37

17.29

1.3

1.5

2970.8

2238.8

e6/l

0.12

735

4682

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

1120

7553

1.32

17.17

2.7

3.6

g/l

0.20

1049

7217

(3028433) Virus identified in Specimen by Culture

181

798

2.01

17.11

1.3

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

384

2121

1.61

17.05

1.9

2.0

0.7

1.0

g/24h

0.47

118

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

249

1224

1.81

16.96

1.1

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

271

1368

1.76

16.88

2.3

2.0

100.6

99.6

0.20

247

1291

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

336

2.59

16.74

1.1

1.0

94.8

80.5

ug/l

2.11

279

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

188

847

1.97

16.73

2.2

2.6

1.2

1.0

ug/l

0.54

172

805

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

433

2473

1.56

16.68

1.2

—

(3051611) Lipemic interference index of Serum or Plasma

459

2660

1.53

16.57

3.5

3.4

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

417

2369

1.57

16.45

1.4

138252.8

97706.6

e6/l

0.59

264

1663

(3021387) Prolactin [Units/volume] in Serum or Plasma

1200

8221

1.30

16.42

1.7

292.0

306.3

mu/l

0.72

1087

7464

(3008037) Lactate [Moles/volume] in Venous blood

832

5403

1.37

16.39

4.1

3.0

1.5

1.6

mmol/l

1.92

814

5293

(3038515) Glucose [Moles/volume] in Venous blood

789

5083

1.38

16.33

4.2

3.1

7.4

7.6

mmol/l

0.91

772

4993

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

367

2029

1.61

16.26

1.1

1.2

36.8

44.9

mg/l

2.32

310

1707

(37021550) Renin [Units/volume] in Plasma --upright

127

499

2.26

16.14

1.2

1.3

65.4

78.5

mu/l

0.23

375

(3047352) Trisomy 18 risk [Likelihood] in Fetus

264

3944

0.59

16.14

1.5

1.4

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

1179

8079

1.30

16.12

2.5

2.4

93.5

92.0

1.52

1093

7522

(3016018) Differential panel - Cerebral spinal fluid

481

2837

1.51

16.01

1.3

1.5

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

354

1948

1.62

16.00

1.1

268.2

280.8

mg/l

0.31

319

1717

(40762887) Creatinine [Moles/volume] in Blood

6.47

15.92

1.2

—

(40762814) Titanium [Mass/volume] in Blood

112

420

2.37

15.86

2.3

3.1

3.7

ug/l

0.89

140

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

266

1361

1.74

15.85

2.1

2.5

1112.5

1091.4

u/ml

0.03

261

1347

(3005033) Fetal Nuchal fold Thickness US

265

3933

0.59

15.80

1.5

1.4

—

(1761482) Bacteria [#/volume] in Urine by Culture

957

6390

1.33

15.75

4.9

3.9

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

275

4039

0.60

15.72

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

153

655

2.07

15.71

1.3

1.2

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

233

1150

1.80

15.71

1.2

1.1

6.4

14.7

u/ml

0.79

100

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

327

1779

1.63

15.49

1.6

1.5

22.6

24.9

u/ml

0.40

372

(3011436) Histone Ab [Units/volume] in Serum

127

508

2.22

15.49

1.1

—

40.6

u/ml

—

(3036670) Protein [Mass/volume] in Synovial fluid

162

715

2.01

15.33

1.3

40.7

39.9

g/l

0.27

394

(1761868) Lipid panel - Serum or Plasma

10591

100473

0.91

15.12

3.1

2.8

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

199

947

1.87

15.10

1.7

1.9

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

189

3.05

15.08

1.0

3.0

4.9

u/ml

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

997

6741

1.32

15.05

1.2

1.1

—

(3009015) Lactate [Moles/volume] in Synovial fluid

237

2.81

15.03

1.4

1.2

5.6

6.4

mmol/l

0.64

124

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

148

637

2.06

15.01

1.7

131.0

137.8

au/ml

0.04

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

369

2088

1.57

14.87

1.9

2.0

2.2

2.3

u/field

0.11

194

853

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

233

1176

1.76

14.61

4.2

3.7

—

(40757373) Influenza virus identified in Isolate

114

448

2.26

14.54

1.7

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

102

382

2.37

14.53

1.1

3.6

6.1

u/ml

0.30

269

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

211

1036

1.81

14.52

1.1

451.5

638.6

ng/l

0.28

250

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

144

622

2.05

14.48

1.3

131.1

120.6

nmol/l

0.37

113

444

(3024932) HLA-DR beta [Type]

170

781

1.93

14.38

1.1

—

(4306422)

608

3832

1.41

14.38

1.2

—

(3024471) HLA-A [Type]

173

803

1.91

14.20

1.0

—

(21494814) CD8 cells/100 lymphocytes in Specimen

206

1012

1.81

14.16

1.6

2.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

410

2402

1.52

14.16

1.3

—

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

4.99

14.13

1.1

0.2

g/l

0.30

(3020874) Milk IgE Ab [Units/volume] in Serum

283

1521

1.65

14.12

1.0

1.1

1.0

1.7

u/ml

0.76

106

423

(3020891) Body temperature

1403

9995

1.25

14.04

5.6

4.6

—

(3028707) Methadone [Presence] in Urine by Screen method

589

3711

1.41

13.97

2.5

2.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

138

596

2.05

13.91

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

265

1408

1.67

13.83

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

720

4700

1.36

13.81

1.7

1.6

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

282

1525

1.64

13.75

1.1

ratio

0.22

550

(3019230) Fractional oxyhemoglobin in Venous blood

659

4256

1.38

13.53

3.7

3.1

65.5

64.8

0.35

654

4234

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

191

932

1.82

13.45

2.5

2.7

—

(3011288) Drugs identified in Urine by Screen method

867

5849

1.32

13.35

2.6

2.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

604

3855

1.39

13.32

1.1

—

(3006576) Bicarbonate [Moles/volume] in Blood

177

847

1.85

13.27

5.4

6.4

24.4

25.3

mmol/l

2.26

160

778

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

440

2652

1.47

13.27

1.2

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

203

1014

1.78

13.24

3.2

5.5

2163.8

2568.2

mg/l

0.09

130

742

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

195

2.86

13.17

1.1

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

768

5103

1.34

13.15

1.2

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

137

608

2.00

12.86

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

137

608

2.00

12.86

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

137

608

2.00

12.86

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

137

608

2.00

12.86

1.1

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

208

2.77

12.80

1.0

0.1

0.2

u/ml

0.41

127

(21494890) Protein electrophoresis panel - 24 hour Urine

416

2504

1.48

12.66

1.8

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

613

3960

1.38

12.60

1.2

3.7

4.0

u/ml

0.16

221

1353

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

314

2.40

12.55

1.1

0.0

0.5

u/ml

1.88

198

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

314

2.40

12.55

1.4

95319.6

298509.0

nmol/l

0.82

267

(3043410) Blood group antigens tested for on Red Blood Cells

142

645

1.95

12.49

1.6

1.8

—

(3044941) Cell count panel - Synovial fluid

618

4005

1.37

12.46

1.5

1.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

252

2.57

12.43

2.0

2.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

215

1115

1.71

12.34

1.9

2.3

122.8

246.8

ug/l

0.42

208

1060

(3043409) Potassium [Moles/volume] in Arterial blood

1076

7550

1.27

12.30

4.9

4.3

3.9

mmol/l

0.53

1021

7083

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

280

2.47

12.25

1.9

2.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

204

1045

1.73

12.24

1.1

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

580

3732

1.38

12.23

1.1

122.0

118.0

2.29

527

3375

(3004451) EKG impression Narrative

225

1186

1.68

12.17

1.4

1.2

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

437

2677

1.45

12.17

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

135

609

1.97

12.13

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

254

1385

1.63

12.06

1.1

—

(4268621)

420

2559

1.46

12.04

2.2

2.3

—

(3008402) Methanol [Moles/volume] in Serum or Plasma

246

2.56

12.01

1.4

1.2

—

1.0

mmol/l

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

771

5197

1.32

12.00

1.9

1.7

—

(3019174) dRVVT (LA screen)

201

2.73

11.94

1.2

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

168

821

1.82

11.84

2.9

3.3

7.7

7.9

mg/l

0.21

127

650

(3001964) Herpes simplex virus Ag [Presence] in Specimen

149

703

1.88

11.74

1.8

1.4

—

(3025549) Creatine [Moles/time] in 24 hour Urine

198

2.73

11.73

1.5

1.4

—

13.1

—

(3045142) Bone marrow Pathology biopsy report

444

2750

1.43

11.68

1.3

—

(3033942) Copper [Moles/time] in 24 hour Urine

3.68

11.59

1.0

1.2

0.3

0.7

umol/24h

0.82

(3011841) English Walnut IgE Ab [Units/volume] in Serum

211

2.65

11.42

1.0

1.1

0.2

4.7

u/ml

2.40

162

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

104

438

2.11

11.30

2.2

2.6

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

186

951

1.74

11.28

2.0

2.2

29.7

29.0

0.25

179

900

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

234

2.54

11.18

1.0

1.1

1.7

1.8

umol/24h

0.36

234

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

215

1148

1.66

11.13

1.9

138.4

146.7

0.86

197

1086

(3006245) CD3-CD19+ cells/100 cells in Blood

188

969

1.72

11.09

2.1

2.4

10.9

10.7

0.09

177

904

(3027456) Digoxin [Moles/volume] in Serum or Plasma

677

4536

1.33

11.03

3.1

0.8

nmol/l

0.20

517

3527

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

339

2.25

11.02

1.1

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

189

978

1.71

11.00

2.7

2.3

—

(3024869) Neuronal Ab [Presence] in Serum

103

437

2.09

10.99

1.1

—

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

124

3.14

10.86

1.4

2.0

163.7

184.8

ug/g

0.39

106

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

120

541

1.97

10.86

1.4

21.8

22.1

0.04

100

453

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

418

2598

1.43

10.83

1.3

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

1254

9089

1.23

10.80

2.0

1.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

437

2740

1.42

10.79

1.6

1.5

34.0

29.6

iu/ml

0.25

110

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

1056

7517

1.25

10.74

1.3

221.8

219.2

miu/ml

0.08

437

3425

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

1315

9584

1.22

10.74

1.7

4.8

3.3

mg/l

2.15

1010

6715

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

116

3.21

10.72

1.0

0.2

0.4

u/ml

0.58

107

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1051

7486

1.25

10.63

1.3

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

154

762

1.79

10.49

2.6

2.8

190.8

164.8

au/ml

0.31

101

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

274

1575

1.54

10.48

1.6

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

814

9156

0.78

10.47

1.5

—

(40768446) Kidney Pathology biopsy report

189

992

1.69

10.47

1.9

1.6

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

173

890

1.72

10.31

1.2

1.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

109

485

1.99

10.27

1.3

1.2

19.4

31.7

mg/l

0.21

359

(3014599) Egg white IgE Ab [Units/volume] in Serum

264

1513

1.55

10.25

1.0

1.1

3.6

2.7

u/ml

0.18

364

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

213

2.54

10.22

1.0

9.2

2.1

u/ml

0.34

115

(3019977) pH of Arterial blood

242

1363

1.58

10.14

2.4

2.5

7.4

1.09

472

(40762365) Oxygen content in Arterial blood by calculation

392

2.10

10.14

2.3

3.1

15.1

14.8

ml/dl

0.63

361

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

487

3146

1.38

10.12

1.7

1.9

22.3

24.8

ug/l

0.35

473

3090

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

458

2930

1.39

10.10

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1676

12575

1.19

10.08

1.4

1.3

27.8

30.9

iu/l

3.42

1431

10862

(3010015) Selenium [Moles/volume] in Serum or Plasma

184

2.65

10.04

1.9

2.0

1.3

umol/l

0.41

161

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

742

1.78

9.96

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

886

6238

1.26

9.94

2.5

2.4

104.9

107.4

ug/min

0.05

510

3712

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

121

566

1.90

9.88

1.1

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

106

477

1.97

9.70

2.3

2.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

358

2.13

9.70

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

177

933

1.68

9.69

1.2

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

293

1740

1.50

9.67

1.4

12.7

12.5

u/l

0.25

278

1683

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

155

790

1.74

9.59

1.1

93.3

88.2

0.99

372

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

383

2399

1.42

9.57

4.2

4.9

93.6

108.6

u/ml

0.20

101

744

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

139

2127

0.58

9.56

1.2

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

131

636

1.83

9.54

1.2

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

329

2005

1.46

9.54

1.7

1.4

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

210

2.49

9.54

1.1

1.0

0.1

0.9

u/ml

0.98

113

(3012565) Volume of 24 hour Urine

232

1315

1.57

9.50

2.1

2.2

1885.7

1982.9

0.75

209

1163

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

195

2.55

9.47

1.9

2.7

—

(3029075) Extractable nuclear Ab panel - Serum

145

728

1.77

9.46

1.1

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

510

3365

1.35

9.31

1.1

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

192

2.54

9.26

1.8

1.7

54.0

45.2

umol/l

0.81

192

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

223

1261

1.57

9.24

1.8

2.5

197.0

207.5

u/l

1.28

223

1250

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

209

2.46

9.15

1.2

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

209

2.46

9.15

1.2

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

431

2779

1.38

9.12

1.1

94.9

96.4

0.58

396

2608

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

241

1393

1.54

9.07

1.1

u/l

0.15

114

641

(3052592) Norovirus Ag [Presence] in Stool

102

466

1.94

8.98

1.2

1.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

244

1418

1.53

8.96

1.7

1.4

—

(44806071)

318

2.15

8.90

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

196

2.49

8.90

1.1

1.0

0.2

0.7

u/ml

0.84

109

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

429

5142

0.74

8.89

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2539

25385

0.88

8.86

1.8

1.7

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

119

575

1.84

8.84

1.1

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

224

2.37

8.79

1.0

1.1

0.2

2.6

u/ml

1.61

174

(3009871) Measles virus Ab [Titer] in Serum

164

871

1.67

8.78

1.5

1.7

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

6050

49678

1.09

8.75

3.2

2.9

0.7

0.8

ug/l

9.55

4050

32402

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

156

819

1.69

8.73

1.1

1.2

110.3

107.8

0.35

133

756

(3042111) Morphology [Interpretation] in Bone marrow Narrative

586

3985

1.31

8.70

1.6

—

(3008536) Aspergillus sp Ab [Presence] in Serum

103

478

1.91

8.67

1.7

2.3

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

242

2.31

8.67

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

949

6844

1.23

8.66

2.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

299

2.16

8.63

2.1

2.5

0.6

u/field

0.24

299

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

267

1599

1.48

8.52

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

240

1406

1.51

8.52

1.7

1.4

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

154

812

1.68

8.49

1.1

91.0

88.7

0.42

377

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

215

1234

1.55

8.39

1.2

1.3

57.6

62.4

0.21

148

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

238

1397

1.51

8.38

1.4

1.6

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

323

4003

0.71

8.30

1.7

1.8

—

(40768793) Breast Pathology biopsy report

845

6047

1.24

8.30

1.4

1.3

—

(3049242) von Willebrand panel - Platelet poor plasma

3.57

8.17

2.0

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

378

1.99

8.12

2.5

3.2

—

(3000060) B lymphocytes [#/volume] in Blood

139

722

1.71

8.12

2.1

2.3

413.8

638.4

e6/l

0.24

387

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

137

2.72

8.12

1.6

1.3

18.6

17.6

pmol/l

0.13

122

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

406

4831

0.74

8.07

1.4

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

842

6046

1.24

8.04

1.4

143.0

138.3

pmol/l

0.09

823

5903

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

148

2.63

8.03

1.0

1.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

474

3167

1.33

8.02

1.1

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

188

1058

1.58

8.02

1.6

1.8

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

407

4834

0.74

7.99

1.4

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

211

1221

1.53

7.97

1.2

1.3

4.1

4.6

umol/l

1.22

187

1127

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

269

2.17

7.93

1.1

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

165

2.52

7.88

1.3

1.2

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

405

4800

0.74

7.84

1.4

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

156

844

1.64

7.84

2.0

166.0

169.8

0.14

143

806

(40763480) Human metapneumovirus Ag [Presence] in Specimen

115

2.85

7.83

1.4

1.3

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

407

4818

0.75

7.82

1.4

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

555

3806

1.30

7.80

4.7

5.1

348.6

370.8

umol/l

3.13

490

3289

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

206

1193

1.53

7.76

1.2

1.1

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

3.73

7.73

1.0

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

163

896

1.61

7.69

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

3.49

7.62

1.1

1.3

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

122

2.76

7.59

1.2

1.1

62.3

107.3

u/l

0.41

102

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1654

16844

0.86

7.56

1.5

1.4

—

(3018133) Calcium [Moles/volume] in Urine

412

1.89

7.30

1.8

2.0

2.9

2.6

mmol/l

0.80

368

(3028717) Thiamine [Mass/volume] in Blood

245

2.17

7.22

1.1

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

117

600

1.73

7.22

1.2

1.3

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

131

2.64

7.17

1.0

0.2

1.8

u/ml

0.96

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

142

2.56

7.11

5.3

4.9

—

(3051651) Icteric interference index of Serum or Plasma

248

1522

1.45

7.08

3.8

3.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

100

495

1.79

6.98

2.3

2.4

7.3

7.5

mmol/l

0.22

291

(3023410) Appearance of Cerebral spinal fluid

400

2666

1.33

6.96

1.4

1.7

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

140

762

1.63

6.93

1.0

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1442

11035

1.16

6.92

1.9

1.8

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

268

1679

1.42

6.85

1.1

—

(3033799) Differential panel - Peritoneal fluid

123

650

1.68

6.83

1.7

—

(3011897) Casein IgE Ab [Units/volume] in Serum

391

1.88

6.79

1.1

1.3

0.3

3.4

u/ml

2.15

(3050129) First trimester maternal screen panel - Serum or Plasma

534

5975

0.79

6.74

1.5

1.4

—

(3003338) MCHC [Mass/volume]

25797

232749

0.94

6.73

24.1

16.6

332.0

332.6

g/l

21.03

25657

230976

(3036312) Salmon IgE Ab [Units/volume] in Serum

136

2.54

6.69

1.1

0.7

1.3

u/ml

0.32

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

138

756

1.62

6.67

1.3

1.5

73.8

72.3

0.58

133

724

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

5.17

6.66

1.0

1.1

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

132

717

1.63

6.61

1.2

1.1

—

(3041672) Baker's yeast Ab [Presence] in Serum

108

2.71

6.41

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

194

2.24

6.39

1.2

1.1

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

178

2.29

6.33

1.3

1.2

12.3

23.7

0.86

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

134

740

1.61

6.30

1.3

1.5

1177.4

661.9

mu/l

0.32

129

708

(3000034) Microalbumin [Mass/volume] in Urine

358

2385

1.33

6.30

3.0

49.3

51.5

mg/l

0.05

264

1693

(3020123) Porphyrins [Interpretation] in Serum or Plasma

135

2.49

6.29

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

131

721

1.61

6.25

1.4

1.3

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

125

2.55

6.25

1.7

1.6

187.4

197.8

ng/l

0.39

114

(43055442) Apixaban [Mass/volume] in Serum or Plasma

303

1.96

6.22

1.7

1.5

122.6

107.7

ug/l

0.49

244

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

146

826

1.57

6.21

1.1

—

(4027681)

248

1562

1.41

6.20

1.3

—

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

3.36

6.14

1.3

1.7

228.3

272.6

nmol/l

0.15

(40763791) Oxygen content in Venous blood by calculation

3.17

6.14

5.0

7.6

12.0

12.4

ml/dl

0.20

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

192

2.22

6.13

5.9

6.0

—

(3020650) Glucose [Presence] in Urine

125

686

1.62

6.05

1.4

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

288

1.97

6.03

1.1

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

5.01

5.98

1.1

1303.1

2805.2

titre

1.65

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.74

5.98

1.5

1.3

—

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

134

2.45

5.91

1.1

15.5

42.3

u/ml

2.20

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

134

2.45

5.91

1.1

28.3

22.4

u/ml

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

173

2.25

5.87

1.4

1.2

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

304

1.92

5.83

1.3

1.2

—

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

168

2.27

5.82

2.3

4.1

1.9

2.2

mg/l

0.59

138

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

563

4019

1.24

5.81

1.1

26.6

3440.6

iu/ml

0.73

123

866

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

268

1.98

5.79

2.0

1.6

1.3

1.7

mg/l

1.46

225

(3025577) Chromium [Mass/volume] in Blood

243

1546

1.39

5.77

2.1

2.2

2.3

ug/l

0.23

196

1304

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

185

1120

1.47

5.76

1.1

1.0

99.7

97.8

0.31

153

887

(3026470) Cobalt [Mass/volume] in Blood

250

1599

1.39

5.75

2.1

2.0

3.1

3.8

ug/l

0.94

215

1406

(3015076) Soybean IgE Ab [Units/volume] in Serum

220

1377

1.42

5.74

1.0

0.3

1.0

u/ml

0.86

164

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1774

13963

1.13

5.73

2.0

1.9

—

(3016879) Cocaine [Presence] in Urine

1095

8337

1.17

5.69

2.0

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

1.1

2.1

mg/l

1.38

122

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

1.4

0.9

mg/l

0.28

133

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

2.4

1.7

mg/l

0.34

126

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

2.3

2.4

mg/l

0.03

143

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

2.3

2.6

mg/l

0.14

138

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

2.6

3.9

mg/l

0.99

123

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

0.4

1.3

mg/l

2.18

127

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

3.6

2.3

mg/l

0.68

131

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

187

2.18

5.68

1.8

1.6

2.0

1.8

mg/l

0.15

140

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

193

2.16

5.66

1.8

1.6

2.1

1.8

mg/l

0.18

134

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

247

2.01

5.61

2.2

2.4

1.1

1.5

mmol/l

0.54

178

(3047189) Immunofixation for 24 hour Urine

183

1115

1.46

5.54

1.7

1.9

—

(3012441) Differential panel - Pleural fluid

367

2503

1.30

5.53

1.5

1.4

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

355

1.82

5.49

1.2

1.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

214

1347

1.41

5.44

2.0

2.2

27.2

30.4

umol/l

0.11

113

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

497

3533

1.25

5.36

1.3

7.0

7.3

mmol/l

1.19

355

2545

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

204

2.09

5.33

2.9

2.7

22.7

mg/l

0.01

184

(3008116) Ketones [Moles/volume] in Urine by Test strip

477

1.69

5.31

1.8

1.3

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

3.05

5.30

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

383

2643

1.29

5.30

1.5

1.4

78772.1

51417.6

e6/l

0.63

241

1594

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

109

2.52

5.29

1.3

1.6

0.3

0.1

u/l

0.33

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

419

1.73

5.25

5.5

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

273

1801

1.34

5.22

1.3

1.4

12.6

12.2

umol/l

0.47

258

1715

(3012989) Citrate [Moles/time] in 24 hour Urine

3.73

5.20

1.3

1.6

2.3

mmol/24h

1.53

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

427

1.72

5.19

1.3

1.4

64.1

124.9

ng/l

1.58

267

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

223

1426

1.39

5.19

1.2

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

325

2201

1.31

5.19

1.4

1.3

672.6

487.4

u/l

0.45

305

2102

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

362

1.79

5.18

1.2

1.4

55.5

51.0

0.31

170

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

415

1.73

5.15

1.1

3.3

7.5

pmol/l

0.53

(3023487) Leukocytes [#/volume] in Peritoneal fluid

132

765

1.53

5.13

2.1

1.7

675.9

5371.7

e6/l

2.12

505

(3023199) Leukocytes [#/volume] in Pleural fluid

416

2913

1.27

5.13

1.5

1.4

4934.1

2873.0

e6/l

0.44

316

2119

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

667

1.57

5.12

1.1

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

416

1.73

5.11

1.7

2.3

1.2

mmol/l

0.34

400

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

146

866

1.49

5.09

1.1

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

156

2.22

5.04

1.1

1.2

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

119

677

1.56

5.03

1.1

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

191

2.09

5.03

1.2

18.4

14.6

nmol/l

0.91

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

379

1.75

5.01

4.7

5.1

57.5

43.7

ug/min

0.79

304

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

472

1.67

5.00

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

118

672

1.56

4.97

1.2

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

473

1.67

4.97

1.2

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

473

1.67

4.97

1.2

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

303

2047

1.31

4.95

1.3

87.5

87.8

pmol/l

0.00

131

639

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

141

836

1.50

4.94

1.7

2.0

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

279

3247

0.76

4.94

1.4

1.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

101

556

1.61

4.92

1.1

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

262

1735

1.34

4.92

1.3

13.6

14.3

u/l

0.13

238

1610

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

144

862

1.48

4.83

1.2

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

371

1.74

4.80

1.5

1.4

0.2

0.3

nmol/l

1.30

254

(43055514) Macroprolactin [Presence] in Serum or Plasma

101

561

1.60

4.76

1.2

1.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

202

2.02

4.72

3.0

2.7

—

(3035320) C reactive protein [Mass/volume] in Body fluid

280

1885

1.32

4.71

2.6

2.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

420

1.69

4.70

2.4

2.7

47.5

55.4

mg/l

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

239

1573

1.35

4.69

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

328

1.78

4.69

1.7

1.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

290

1.83

4.67

1.2

1.1

—

(3036603) Volume of Urine

259

1732

1.33

4.58

1.7

1.6

1874.0

1991.6

0.63

379

(3026692) Albumin [Mass/volume] in Peritoneal fluid

512

1.61

4.56

1.5

1.3

12.9

14.3

g/l

0.80

405

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

169

2.10

4.56

1.2

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

171

1072

1.41

4.53

2.5

2.4

56.9

53.0

umol/l

0.80

141

893

(3003434) Protein [Mass/volume] in Pleural fluid

453

3254

1.24

4.53

1.5

1.4

33.6

33.4

g/l

0.13

410

2949

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

152

2.16

4.52

1.0

0.0

2.2

u/ml

2.03

107

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

332

1.76

4.52

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

116

674

1.53

4.51

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

400

4399

0.80

4.50

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

314

1.78

4.46

1.0

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

111

641

1.54

4.45

1.5

1.3

42.5

39.4

0.35

426

(21491868) Cryoglobulin [Mass/volume] in Serum

143

871

1.46

4.43

1.2

1.0

0.3

g/l

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

220

1446

1.35

4.39

2.6

2.8

39.0

38.8

0.04

468

(3013727) Leukocytes other/100 leukocytes in Blood

136

822

1.47

4.39

3.8

3.7

49.6

52.8

0.98

130

794

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

2.95

4.38

3.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

223

1470

1.35

4.37

1.4

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

358

2517

1.26

4.34

1.6

1.5

32.8

30.6

0.50

211

1566

(3021162) Amylase [Enzymatic activity/volume] in Specimen

396

1.68

4.34

2.4

2.9

2740.1

1278.7

u/l

0.39

358

(3004775) Volume in Urine collected for unspecified duration

297

2041

1.29

4.33

2.4

2.2

706.4

667.5

0.88

209

1344

(3013336) Amino acids [Identifier] in Serum or Plasma

3.14

4.33

3.4

2.0

—

(3001556) Androgen free Index in Serum or Plasma

203

1.96

4.32

1.3

1.2

—

(3034988) Calcium [Moles/volume] in Capillary blood

451

1.63

4.31

2.0

2.5

1.2

mmol/l

0.25

434

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

295

2027

1.29

4.31

1.8

1.9

4.0

3.7

mg/l

0.61

279

1927

(4198724)

163

1024

1.41

4.29

1.9

2.2

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

318

1.76

4.29

2.7

2.5

71.7

57.7

pmol/l

0.34

272

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

365

1.70

4.25

1.2

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

174

2.04

4.25

1.0

1.1

6.8

10.7

u/l

1.20

174

(4034850)

1122

8759

1.14

4.23

11.1

9.2

—

(3025315) Body weight

205

1.95

4.21

4.5

4.3

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

254

1719

1.31

4.17

1.0

305.0

338.8

ng/l

0.63

179

1214

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

111

651

1.51

4.17

1.2

1.3

121.7

307.8

ug/l

1.10

352

(3001686) Cold agglutinin [Titer] in Serum or Plasma

435

1.63

4.16

1.4

1.3

77.3

193.0

titre

—

(4133840)

124

745

1.48

4.15

1.2

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

243

1636

1.32

4.15

5.8

6.6

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

318

2221

1.27

4.11

1.2

1.3

11.4

11.8

mmol/l

0.28

564

(3016750) Collection duration of Urine

224

1493

1.33

4.10

2.2

2.1

511.1

498.4

min

1.23

177

1065

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

126

762

1.47

4.09

2.4

2.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

126

762

1.47

4.09

2.4

2.5

—

(40768806) Pleura Pathology biopsy report

355

2520

1.25

4.00

1.6

1.5

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

113

673

1.49

3.97

2.0

1.6

12842.8

10648.6

e6/l

0.12

351

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

103

2.32

3.96

1.0

1.2

280.0

504.5

u/l

0.77

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

254

1733

1.30

3.96

1.0

40.2

42.6

ng/l

0.36

175

1199

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

428

1.62

3.93

1.5

1.6

—

(40765096) Chromosome analysis panel by Banding

119

719

1.47

3.90

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

253

1730

1.30

3.88

1.0

792.1

738.0

ng/l

0.97

173

1176

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

321

2262

1.26

3.87

1.4

1.3

1.5

1.4

nmol/l

0.54

292

2044

(3015183) Erythrocyte sedimentation rate

199

1316

1.34

3.87

1.3

1.2

—

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

145

2.08

3.84

1.1

1.4

4.2

3.6

u/ml

0.05

125

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

270

1.77

3.83

1.1

—

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

116

2.21

3.83

1.0

6.6

17.4

u/ml

1.68

(3032641) Amino acids panel - Urine

4.22

3.80

1.1

—

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

3.26

3.80

1.0

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

106

630

1.49

3.78

1.1

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

452

0.45

3.76

3.7

3.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

214

1.86

3.75

1.0

1.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

451

0.45

3.74

7.5

6.4

—

(44806420)

110

662

1.47

3.70

2.3

2.4

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

380

2746

1.23

3.68

1.6

1.5

—

(3049233) Organic acids panel - Urine

3.54

3.67

1.3

1.2

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

205

1374

1.32

3.66

1.3

5.9

5.8

mmol/l

0.78

194

1288

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

176

1155

1.35

3.63

1.5

1.6

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

176

1156

1.35

3.61

1.5

1.6

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

211

1.85

3.59

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

1137

8988

1.12

3.57

2.0

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

212

1.84

3.55

1.3

11.6

14.0

pmol/l

0.26

182

(3036071) Salmonella sp Ab [Titer] in Serum

129

809

1.41

3.51

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

526

1.52

3.51

1.2

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

493

3673

1.19

3.50

1.5

1.4

0.3

0.4

nmol/l

0.24

385

2769

(3006567) Chloride [Moles/time] in 24 hour Urine

2.95

3.49

1.1

—

(3050794) Legionella sp Ab [Presence] in Serum

220

1.81

3.47

1.1

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

7.75

3.47

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

158

1028

1.36

3.46

1.6

1.9

—

(3044007) Cell count panel - Peritoneal fluid

102

614

1.47

3.45

2.1

1.7

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.61

3.45

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

340

1.64

3.44

1.7

1.6

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

192

1288

1.32

3.44

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

103

622

1.47

3.44

10.1

8.4

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.85

3.41

1.0

—

(3028300) Cannabinoids [Presence] in Urine

1143

9066

1.12

3.41

2.0

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

228

1.79

3.40

1.2

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.42

3.38

1.0

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

288

1.69

3.37

1.4

1.3

110.5

81.7

u/l

0.15

209

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

461

1.54

3.34

3.9

5.5

46.4

51.8

u/l

0.28

190

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

364

1.61

3.32

1.1

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

119

746

1.41

3.27

1.2

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

340

0.42

3.24

1.4

1.2

—

(3042628) Porphyrins [Moles/volume] in Urine

8.86

3.23

1.2

1.0

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

181

1.86

3.20

1.4

1.1

44.0

46.2

mg/l

0.14

(3034891) Synovial lining cells/100 cells in Synovial fluid

192

1303

1.31

3.20

1.5

5.2

3.9

0.45

291

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

438

1.54

3.19

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

404

1.56

3.16

1.7

1.5

—

(3023383) Lactate [Moles/volume] in Pleural fluid

116

732

1.40

3.10

1.4

1.3

3.2

3.6

mmol/l

0.75

101

677

(3018001) Oat IgE Ab [Units/volume] in Serum

158

1.91

3.09

1.0

0.2

0.3

u/ml

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

542

1.47

3.09

1.1

1.2

64.8

76.6

1.03

150

(3003694) ABO and Rh group [Type] in Blood

8632

73944

1.04

3.03

1.4

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

205

1.77

2.99

1.2

1.1

18.3

17.5

iu/ml

—

(3027008) Opiates [Presence] in Urine

1132

9051

1.11

2.97

2.0

1.9

—

(3017569) Oxygen content in Arterial blood

172

1164

1.31

2.96

2.2

2.1

—

(3007456) Orange IgE Ab [Units/volume] in Serum

2.66

2.93

1.1

1.0

0.0

0.3

u/ml

—

(3024263) Appearance of Synovial fluid

199

1375

1.28

2.93

2.3

1.7

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

200

1.77

2.92

1.2

104.2

96.5

ug/l

0.14

126

(3034426) Prothrombin time (PT)

132

862

1.36

2.90

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

248

1.68

2.86

2.3

2.6

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

559

1.44

2.85

8.5

5.7

66.2

70.9

0.81

455

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.14

2.84

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.14

2.84

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.14

2.84

1.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.14

2.84

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.14

2.84

2.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.14

2.84

2.0

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

211

1477

1.27

2.82

12.0

12.3

0.6

mmol/l

3.19

191

1353

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

189

1305

1.28

2.82

1.1

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

228

1611

1.25

2.81

18.0

17.5

1373.9

3435.6

nmol/l

1.05

215

1542

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

2.24

2.78

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

538

4125

1.16

2.77

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

114

1374

0.73

2.77

1.3

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

191

1.76

2.75

1.9

3.0

6.6

396.0

pmol/l

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

185

1279

1.28

2.74

1.2

1.1

3.2

4.5

iu/ml

0.99

(3042517) Benzodiazepines panel - Urine

245

1.66

2.72

2.2

2.7

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

558

1.43

2.70

1.3

1.2

107.9

109.1

0.13

531

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

122

1.96

2.70

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.16

2.70

1.0

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

199

1.74

2.69

1.4

1.3

1.5

ml/s/173m2

0.21

130

(3003740) Influenza virus B Ag [Presence] in Specimen

537

4129

1.15

2.68

1.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

294

1.60

2.68

1.3

1.2

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

148

1.86

2.65

1.1

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

220

1.69

2.64

1.0

1.1

—

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

2.19

2.64

1.2

2554.7

3428.3

ng/l

0.29

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

116

755

1.36

2.64

1.2

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

174

1.78

2.63

2.0

1.8

58.0

59.2

0.05

113

(3002331) Protein [Mass/volume] in Peritoneal fluid

466

1.46

2.63

1.3

24.4

42.9

g/l

0.86

377

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

2.80

2.58

1.0

1.2

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

100

2.04

2.56

19.5

12.6

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

2.53

2.52

1.9

2.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

177

1.75

2.51

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

2.13

2.50

1.1

155.7

235.8

pmol/l

—

(3036782) Glucose [Moles/volume] in Pleural fluid

307

2272

1.20

2.47

1.4

1.3

6.2

6.3

mmol/l

0.17

281

2107

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

2.01

2.38

1.0

1.1

—

(4212803)

187

1.71

2.37

1.2

1.1

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

544

1.40

2.36

1.1

1.2

90.3

87.3

0.15

160

(3038071) Oxygen [Partial pressure] in Mixed venous blood

553

1.39

2.33

10.6

8.3

—

(3045716) Anion gap in Serum or Plasma

170

1191

1.27

2.32

2.9

2.4

8.8

9.2

mmol/l

0.75

105

899

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

140

957

1.30

2.32

2.3

3.0

28.0

28.9

umol/l

0.42

734

(21494567) Legionella sp IgM Ab [Presence] in Serum

182

1.70

2.30

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

163

1138

1.27

2.30

1.1

1503.5

1548.2

miu/ml

0.20

163

1138

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

213

1534

1.23

2.29

12.5

799.2

1478.6

nmol/l

0.53

202

1482

(3000012) Reticulocyte production index

200

1431

1.24

2.28

1.3

1.6

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

393

1.47

2.28

1.9

1.5

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

2.59

2.27

1.1

1.4

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

174

1227

1.26

2.26

2.2

2.1

82.0

109.3

ug/min

0.40

256

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

245

1.59

2.24

1.2

1.1

—

(3013466) aPTT in Blood by Coagulation assay

144

1.78

2.23

1.1

34.8

37.8

2.64

125

(3019832) Treponema pallidum Ab [Presence] in Serum

2490

20837

1.06

2.22

1.7

1.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

125

1.84

2.22

1.2

1.0

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.45

2.21

4.9

5.8

0.3

mmol/l

0.01

(3020393) Adenovirus Ag [Presence] in Stool

289

1.53

2.18

1.4

1.3

—

(3051101) Glucose [Moles/volume] in Cord blood

501

0.62

2.16

4.3

5.7

—

(3041184) Isoniazid [Presence] in Urine

3.07

2.16

2.9

2.4

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.25

2.15

1.5

1.2

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.12

1.2

1.1

—

mmol/l

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

270

1.54

2.12

1.1

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

228

1671

1.21

2.10

2.1

1.7

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

185

1332

1.23

2.04

4.7

5.9

359.2

3586.0

u/ml

0.70

258

(40758292) HTLV I+II Ab panel - Serum

433

1.41

2.03

1.3

1.4

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

316

1.49

2.03

1.0

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

346

1.46

2.00

1.2

1.3

1.9

1.4

mmol/l

0.22

224

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

2.42

2.00

1.0

2.7

0.7

u/ml

—

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

150

1.71

1.98

1.1

1.2

1.4

1.1

u/field

0.61

(3041918) Cholesterol [Moles/volume] in Pleural fluid

443

1.40

1.97

1.3

1.2

1.6

1.7

mmol/l

0.31

269

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

151

1.70

1.94

1.2

1.1

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

3.26

1.89

1.0

1.1

379.4

267.5

nmol/l

—

(3035880) pH of Pleural fluid

182

1321

1.22

1.88

1.3

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.97

1.88

1.4

318.2

536.2

nmol/l

1.75

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

140

1.71

1.84

1.1

2.0

7.2

u/ml

2.26

(3005082) Progesterone [Moles/volume] in Serum or Plasma

997

0.75

1.84

1.4

29.2

30.6

nmol/l

0.18

898

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

119

827

1.28

1.82

1.1

1.2

20.2

20.8

0.03

137

(3036005) Urine sediment comments by Light microscopy Narrative

2.83

1.82

1.0

1.2

—

(3027944) Amphetamines [Presence] in Urine

1088

8918

1.08

1.81

1.9

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

2.14

1.81

11.2

8.3

37.7

44.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.14

1.81

1.0

—

(40768795) Lymph node Pathology biopsy report

350

2699

1.15

1.81

1.2

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

3.10

1.80

1.7

1.0

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

2.26

1.76

1.2

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

2.17

1.75

2.7

2.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

242

1.50

1.69

1.0

1.1

—

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

1.83

1.64

1.0

0.1

0.3

u/ml

0.56

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

172

1266

1.20

1.60

1.2

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

260

2664

0.86

1.58

1.4

4.0

3.9

ug/l

0.03

217

2247

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

113

1.72

1.58

1.3

1.1

u/field

0.14

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

134

1.65

1.55

1.2

2762.7

1001.4

u/l

0.34

122

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

101

1.75

1.53

12.5

8.4

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

1.81

1.52

1.1

1.0

0.1

0.5

u/ml

0.81

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

582

1.29

1.51

1.1

1.2

—

(3017509) Phencyclidine [Presence] in Urine

264

1.44

1.50

1.9

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

514

1.31

1.48

2.6

2.9

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

136

1.63

1.48

1.1

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

150

1.59

1.48

1.6

1.4

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

118

846

1.24

1.45

1.5

1.3

60.7

62.0

0.16

710

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

2.34

1.44

1.0

1.1

—

(3015694) Chlamydophila pneumoniae IgG Ab [Titer] in Cerebral spinal fluid

3.16

1.43

1.2

1.1

—

(3017074) Chlamydophila pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.16

1.43

1.2

1.1

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.12

1.41

3.9

1.9

1.3

2.4

mu/l

0.86

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.87

1.41

1.3

1.7

164.1

117.5

ug/l

—

(3036180) Methadone [Presence] in Urine

2.28

1.40

2.3

2.2

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

1.91

1.39

1.4

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

1692

14229

1.06

1.38

1.7

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

154

1.55

1.35

1.6

1.5

—

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

133

1.60

1.34

1.9

1.7

22.5

16.6

0.28

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.95

1.34

1.0

1.2

18.8

33.0

nmol/24h

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

227

1.44

1.32

9.4

7.1

—

(40768800) Prostate Pathology biopsy report

565

5461

0.91

1.32

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

115

1239

0.82

1.31

1.5

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

148

1.56

1.31

1.2

1.4

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

462

4505

0.91

1.30

3.3

3.5

29.3

38.5

u/ml

1.25

436

4350

(44786800) Granulocytes/100 leukocytes in Body fluid

295

1.38

1.30

1.5

1.3

29.7

23.0

0.63

230

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

100

1.68

1.29

1.2

1.1

0.9

1.0

u/field

0.09

(3044242) Glucose [Moles/volume] in Arterial blood

161

1209

1.18

1.27

2.0

1.9

—

(3001218) Citrate [Mass/time] in 24 hour Urine

2.29

1.26

1.1

1.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

101

1.67

1.25

5.8

5.7

16.1

17.5

mmol/l

0.58

(3034092) Cytoplasmic Ig cells/100 cells in Blood

336

1.34

1.23

10.1

8.0

—

(3002619) Bacteria identified in Specimen by Culture

525

1.27

1.18

1.3

1.2

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

2.01

1.16

1.1

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

2.01

1.16

1.0

—

(3009677) Dengue virus Ab [Presence] in Serum

1.67

1.15

1.1

1.2

—

(3016031) Almond IgE Ab [Units/volume] in Serum

154

1.50

1.13

1.0

0.3

0.9

u/ml

1.23

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

1.73

1.13

1.0

0.2

0.4

u/ml

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

243

1.39

1.12

1.0

1.1

—

(3026480) Teichoate Ab [Titer] in Serum

221

1.40

1.11

1.1

—

2.0

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

112

1.58

1.11

1.1

1.0

0.0

0.2

u/ml

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

192

1.43

1.09

1.1

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

161

1231

1.16

1.06

3.5

3.3

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.65

1.04

1.9

3.6

—

(3007700) Barley IgE Ab [Units/volume] in Serum

107

1.57

1.04

1.0

0.1

0.6

u/ml

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

915

0.82

1.03

2.7

2.4

157.6

154.1

nmol/l

0.07

799

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

158

1.46

1.02

1.1

1.0

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

166

1.44

1.00

2.1

2.7

—

(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma

130

1.50

0.99

1.8

2.4

2.5

10.6

nmol/l

1.22

120

(4038314)

123

1.51

0.98

1.1

1.2

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.98

0.0

1.0

—

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

273

1.33

0.97

1.5

1.4

68.4

72.9

0.40

233

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.59

0.93

1.1

247.4

277.6

nmol/l

0.23

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.21

0.93

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.21

0.93

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

332

0.72

0.93

1.0

1.2

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

2.13

0.91

1.3

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.81

0.89

1.0

1.2

3.4

2.2

—

(3034614) HLA Ag [Interpretation]

1.74

0.87

1.3

1.1

—

(3024316) Viscosity of Plasma

127

1.46

0.87

2.2

1.7

1.8

1.7

mpas

0.29

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

181

1421

1.13

0.86

1.5

1.6

8.2

7.8

mmol/l

1.03

106

857

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.56

0.86

2.0

3.7

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.97

0.85

1.5

1.1

—

(3032868) Hemoglobin electrophoresis panel in Blood

218

1.34

0.85

1.6

1.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

170

0.62

0.85

1.2

1.0

—

(3046861) Legionella sp Ag [Presence] in Urine

143

1.42

0.84

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

158

1.40

0.83

1.4

1.3

304.2

327.3

umol/24h

0.35

158

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.66

0.82

1.0

1.4

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.66

0.82

12.8

8.0

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

129

1.44

0.81

5.3

3.5

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.83

0.79

1.0

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

247

1988

1.10

0.78

1.2

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

101

1.49

0.78

1.1

1.0

0.0

0.1

u/ml

—

(3022689) Creatine [Moles/volume] in Urine

100

761

1.16

0.77

1.4

1.5

—

(3045788) Cell count panel - Pleural fluid

280

2272

1.09

0.75

1.5

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

154

1.38

0.75

1.4

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

200

1.33

0.75

1.9

2.2

—

(3003577) Lead [Moles/volume] in Blood

200

1.33

0.75

1.0

1.5

0.2

umol/l

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

331

2708

1.08

0.74

4.0

3.8

46.7

48.6

u/ml

0.08

323

2681

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

182

1792

0.90

0.74

1.3

1.4

1.5

g/l

0.54

106

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

601

1.18

0.73

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

431

1.21

0.72

6.9

7.4

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

304

1.25

0.71

1.4

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

1.56

0.70

1.1

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

1.56

0.68

1.0

1.2

278.6

408.8

pmol/l

0.54

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

166

1.33

0.66

1.0

—

(3044291) Thermoactinomyces vulgaris IgG Ab [Mass/volume] in Serum

1.77

0.65

1.0

1.1

—

(3008860) Bordetella pertussis IgM Ab [Presence] in Serum

1.59

0.65

1.0

1.4

—

(3037577) Monocytes/100 leukocytes in Cerebral spinal fluid

183

1.31

0.63

1.1

1.5

10.0

12.4

0.41

126

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

1.70

0.62

1.0

1.4

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

1.70

0.62

1.0

1.4

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.61

0.61

1.0

1.1

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.52

0.61

1.0

1.1

—

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

122

0.65

0.61

1.1

1.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

0.61

0.0

1.9

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.58

0.60

1.0

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

147

1.33

0.57

1.0

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

156

1.31

0.55

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.43

0.55

1.0

—

(3013247) Albumin in CSF/Albumin in Serum or Plasma

571

1.15

0.53

1.1

6.2

7.2

mg/g

0.72

539

(3006598) pH of Arterial cord blood

130

0.68

0.52

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

117

0.68

0.52

1.2

—

(3022640) Eosinophils/100 leukocytes in Cerebral spinal fluid

158

1.29

0.51

1.1

1.4

2.1

1.5

0.15

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

312

1.19

0.49

1.1

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

191

1.25

0.49

3.7

5.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

313

1.19

0.47

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.48

0.47

1.0

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.48

0.47

1.1

61.9

98.4

nmol/24h

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

1.36

0.46

1.1

1.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

1.41

0.45

1.0

1.3

—

(3013676) Sertraline [Moles/volume] in Serum or Plasma

1.64

0.43

1.2

1.3

193.7

161.5

nmol/l

—

(40759632) Porphyrins [Mass/mass] in Stool

1.58

0.42

1.0

1.2

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.53

0.41

2.0

2.2

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

719

1.11

0.41

1.5

1.4

2.5

2.8

0.10

620

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

132

1.27

0.41

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

286

1.18

0.40

1.3

1.1

—

(3011544) Albumin [Mass/volume] in Pleural fluid

214

1.20

0.38

1.2

1.1

17.8

17.7

g/l

0.03

198

(3051387) C reactive protein [Mass/volume] in Capillary blood

683

5849

1.03

0.38

4.4

3.2

23.7

26.8

mg/l

1.38

385

3712

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

1050

9054

1.03

0.38

1.4

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

513

0.88

0.37

1.9

2.1

2.9

ug/l

0.64

316

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.35

0.37

1.2

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

607

1.11

0.36

2.3

2.8

121.4

111.8

ng/l

0.19

290

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

135

1.25

0.35

1.0

1.3

—

314.0

—

(3025130) Human papilloma virus identified in Specimen

412

3502

1.04

0.35

1.7

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

136

1119

1.08

0.35

1.6

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

622

0.90

0.35

1.0

—

(3007542) Rye IgE Ab [Units/volume] in Serum

120

1.25

0.34

1.0

0.3

0.4

u/ml

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

193

1.19

0.33

1.0

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.33

0.33

1.2

1.1

—

(3013762) Body weight Measured

0.70

0.31

1.0

1.1

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

693

1.09

0.29

2.2

2.0

17.5

41.9

u/l

3.42

622

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

406

1.11

0.28

1.9

1.8

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

331

1.12

0.28

3.9

3.2

40.8

41.6

umol/l

0.09

286

(4281824)

313

2881

0.96

0.27

1.2

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

124

1.21

0.27

1.1

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

133

0.80

0.27

1.0

—

(3000285) Sodium [Moles/volume] in Blood

316

1.12

0.26

1.2

—

(40758358) Immune stain study

125

1.20

0.25

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.23

0.25

1.0

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.17

0.24

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

667

1.08

0.24

1.7

1.5

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

454

1.09

0.24

1.5

1.2

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

110

1.21

0.23

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

353

1.10

0.23

6.1

9.3

0.3

umol/l

0.20

320

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

210

1.14

0.22

1.1

1.5

44.6

39.2

0.28

134

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

194

1791

0.96

0.22

1.8

—

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.21

0.0

1.4

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3035411) Chaetomium globosum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

296

1.11

0.21

1.1

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

153

1.16

0.20

4.1

2.9

15.5

12.8

0.18

(3022670) pH of Venous cord blood

1.27

0.20

1.0

—

(36303858) Crystals [Presence] in Urine

1.24

0.20

1.0

1.2

—

(3019298) Eosinophils/100 leukocytes in Peritoneal fluid

1.24

0.20

2.2

1.1

0.0

0.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

289

1.10

0.19

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.13

0.18

5.2

3.7

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

996

8693

1.02

0.17

1.4

1.5

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

374

0.92

0.16

1.5

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

216

1.11

0.16

1.3

1.1

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.79

0.15

1.0

1.1

—

(3022475) Manganese [Moles/volume] in Blood

174

1.12

0.15

1.1

1.3

—

(3010937) Rubella virus Ab [Presence] in Serum

133

0.87

0.14

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

159

1.11

0.13

1.1

1.0

—

(40760410) HLA-B [Type] by High resolution

100

1.15

0.13

1.0

—

(40760409) HLA-A [Type] by High resolution

100

1.15

0.13

1.0

—

(46236302) HLA-C [Type] by High resolution typing

100

1.15

0.13

1.0

—

(3035933) Granulocytes/100 leukocytes in Blood

756

1.04

0.12

2.2

1.8

—

(3011325) HIV 1+2 Ab [Presence] in Serum

127

1.12

0.11

1.0

1.1

—

(3013862) HLA-DP [Type]

102

1.13

0.10

1.0

—

(3018291) Platelet Ab [Presence] in Serum

1.08

0.09

1.0

1.1

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

353

1.05

0.09

1.7

1.4

12.4

0.00

186

(3013166) Neutrophils/100 leukocytes in Synovial fluid

820

0.97

0.08

1.5

1.4

54.4

54.9

0.04

694

(1617658) Protocol used for examination of sentinel lymph nodes

234

2106

0.98

0.08

1.0

—

(3039443) Prostate specific Ag panel - Serum or Plasma

572

5018

1.01

0.07

1.6

1.7

—

(3014891) Appearance of Pleural fluid

323

1.04

0.06

1.7

1.6

—

(3022725) Serotonin [Moles/volume] in Serum

1.11

0.06

1.6

1.4

610.2

799.9

nmol/l

0.42

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

322

0.96

0.05

2.3

—

(3007463) Buprenorphine [Presence] in Urine

1.09

0.04

8.5

6.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

290

1.04

0.04

1.4

2.5

—

(3002385) Erythrocyte distribution width [Ratio]

25658

227290

1.00

0.03

22.5

15.8

13.8

13.6

28.04

25267

222373

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

114

0.93

0.03

1.0

—

(3001729) Color of Synovial fluid

213

1.04

0.03

1.5

1.6

—

(40763590) HLA-DQ beta [Type]

100

1.06

0.01

1.0

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

242

1.02

0.01

1.6

1.2

21.0

mmol/l

0.01

194

(46235168) Fasting glucose [Moles/volume] in Blood

314

1.02

0.00

2.2

2.0

6.7

7.5

mmol/l

0.70

125

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

108

0.98

0.00

2.4

1.4

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

240

1.00

0.00

1.1

17.1

20.0

u/l

0.68

145

(3000219) Insulin receptor Ab [Presence] in Serum

0.00

0.0

1.0

—

(3009220) Epithelial cells.squamous [#/volume] in Urine sediment

0.00

0.0

1.1

—

2.2

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

0.85

0.00

1.0

160.2

163.7

g/l

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.5

—

(3028050) Streptolysin O Ab [Titer] in Serum

0.00

0.0

1.0

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

0.93

0.00

1.1

1.3

u/field

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.0

1.7

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3004560) Lymphocytes [#/volume] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.84

0.00

3.2

6.2

—

(3004541) Aldosterone [Moles/volume] in Urine

0.00

0.0

1.3

—

(3039542) Porphyrins [Moles/time] in 24 hour Urine

0.00

0.0

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_REFLUX and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_REFLUX	1.086 [1.0, 1.18]	0.045
Birth year	0.994 [0.99, 1.0]	0.196

During the follow-up period (1.1.1998 — 31.12.2019), 15214 out of 108719 females with K11_REFLUX died.

Males

Parameter	HR [95% CI]	p-value
K11_REFLUX	1.289 [1.19, 1.4]	< 0.001
Birth year	0.988 [0.98, 1.0]	0.012

During the follow-up period (1.1.1998 — 31.12.2019), 18165 out of 94271 males with K11_REFLUX died.

Mortality risk

Mortality risk for people of age

years, who have K11_REFLUX.

N-year risk	Females	Males
1	0.114%	0.243%
5	0.634%	1.493%
10	1.6%	3.681%
15	2.999%	6.704%
20	5.296%	11.685%

Relationships between endpoints

↥

Index endpoint: K11_REFLUX – Gastro-oesophageal reflux disease

GWS hits: 2

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Gastro-oesophageal reflux disease

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints